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ABSTRACT 
Steven Hoberman:  Response Adaptive Designs for Highly Successful       
Treatments, Randomness, and Relationship Detection in Clinical Trials  
 (Under the direction of Michael Kosorok and Anastasia Ivanova) 
In the first part of our research we consider a problem of reducing the expected number 
of treatment failures (a binary response indicator) in trials where the probability of response to 
treatment is close to 1 and treatments are compared based on log odds ratio. We propose a new 
class of urn designs for randomization of patients in a clinical trial. The new urn designs target a 
number of allocation proportions including the allocation proportion that yields the same power 
as equal allocation but significantly less expected treatment failures. The new designs are 
compared with the doubly adaptively biased coin design, the efficient randomized adaptive 
design and with equal allocation. The properties of the new class of designs are studied by 
embedding them into a family of continuous time stochastic processes.    
 In the second part of our research we study entropy as a measure of randomness in a 
clinical trial. For any randomization design we define a sequence of probability distributions. We 
then use this sequence to formulate and prove a statement about conditions for the asymptotic 
mean entropy of a randomization design to achieve its maximum value. We compare 
randomization designs and response adaptive randomization designs with respect to the 
asymptotic mean entropy. We derive a relationship between the limiting variance of distributions 
in the sequence to the mean entropy under a normality condition and apply this result to the 
doubly adaptive biased coin design. 
iv 
We develop two new methods of imputation for survival data that allow for application of 
the Brownian Distance Covariance. We use these two methods with survival data that have 
different levels of censoring, and different relationships that are not all easily detected by the 
Cox model. These methods are also compared to a relationship detection technique developed by 
Kwak for censored data.
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
The clinical trial has long history in biostatistics. One of the most important issues in 
clinical trials is how to assign patients to different treatments. One of the first ways proposed to 
do this is simple randomization. This method involves flipping a coin with a certain success 
probability and assigning patients to one of two treatments depending on the result of the coin 
flip. The problem with this approach is that it can lead to imbalances in the number of patients 
assigned to each treatment that can affect power. One way statisticians have sought to deal with 
this issue is to create more complex treatment assignment regimes that depended on the trial 
assignments previous to the current patient. There are many attractive features of such schemes, 
but one major drawback is that they introduce the possibility for new kinds of bias to enter the 
trial. 
Statisticians conducting clinical trials have long sought ways to mitigate this bias. As 
early as the 1960’s, designs for equal treatment allocations and their possibilities for bias were 
discussed (Stigler, 1969). This was in the case where the total number of patients was fixed. It 
was mentioned that the truncated binomial design was minimax for bias in the case where there 
were two levels of bias,     and    .  Here   is the mean effect of the treatment and   is a 
positive real number indicating bias. The author mentions that even under minimaxity the bias 
does not approach zero asymptotically because the scaling factors cancel. This leads to the 
introduction of a random allocation design, where patients are assigned to treatments by flipping 
a biased coin whose bias depends on the history of the treatment allocation in the trial. Stigler 
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showed that this Bayesian design, which minimizes the Bayes risk of the experimenter’s 
strategy. However, this result depended on the simplicity of the two level distribution of bias 
known to the investigator. 
Efron suggested an allocation scheme that involved flipping a fair coin if the allocation to 
each treatment was equal, and flipping a bias coin with bias towards the less frequent treatment if 
there was imbalance (Efron, 1971). In this scheme, the number of patients in the trial was 
unbounded. He referred to covariate bias as accidental bias. This is the bias that results from 
random differences in covariate values in the patient population. Selection bias, which is also 
important, is defined as the bias that results from the baseline characteristics of the patients 
assigned to each treatment differing due to knowledge that the investigator has about the 
previous patients or (Blackwell and Hodges, 1957). 
Efron also introduced an early method to replace the coin flip as a treatment allocation 
scheme. It is called Efron’s coin (Efron, 1971). The idea is that if the number of patients assigned 
to each treatment is equal then a fair coin is flipped to determine the next treatment assignment; 
if there is an imbalance, then a biased coin with probability p > 0.5 is flipped, and if the coin 
lands heads, then the next patient is selected to decrease the imbalance. The value of p may vary.  
Efron mentioned that the “best” guessing strategy at patient n, if the treatments were 
unmasked and the goal is to guess the next treatment assignment, was to guess the treatment that 
appeared least often (Efron, 1971). This yielded an asymptotic probability of correctly guessing 
the next treatment as 0.5+(r-1)/4r, which implies excess selection bias of (r-1)/4r. Here               
r = p/(1-p). There is an explicit form for the excess selection bias (Markarayan and Rosenberger, 
2010). Efron did not cover a scenario for a coin targeting an allocation different from 0.5. 
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Accidental bias is quantified as being       , where    is the covariance matrix of the 
treatment vector and z is the covariate vector (Efron, 1971).  Recently a compact form for this 
matrix was discovered (Markaryan and Rosenberger, 2010). This bias must be less than the 
maximum eigenvalue of     Efron, 1971), and the upper bound was recently sharpened 
(Markaryan and Rosenberger, 2010).  
The goal of response adaptive designs is to change allocation away from equal allocation 
in order to assign more patients to the better treatment or to reduce the variance of the estimated 
treatment effect or both. One early example of this is the play-the-winner rule. It’s first 
incarnation, (Zelen, 1969), involved switching treatments after a failure on the current treatment 
is observed. The randomized play the winner rule, (Wei, 1978), involves an urn containing two 
different colors of balls. Each time there is a success on a certain treatment, a ball of the 
corresponding color is added to the urn. If there is a failure on that treatment, the opposite color 
of ball is added to the urn. The next treatment is assigned by choosing a ball at random from the 
urn. Both play-the winner rules target the same allocation of   /    +  ) where    is the failure 
probability of treatment i. However, the allocation that both of these treatment allocation 
strategies target is fixed and may not yield optimal power. The average power in a clinical trial is 
a decreasing function of the variability of the allocation proportion (Hu and Rosenberger, 2003).  
Also, researchers desired allocation schemes that were more flexible about the allocation they 
targeted. It is this scenario that motivated the development of the doubly adaptive biased coin 
(DABC), (Hu and Zhang, 2004).  
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The doubly adaptive biased coin chooses the next treatment with probability: 
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Where   is the estimated target allocation for treatment 1, x is the actual target allocation for 
treatment 1, and   is a nonnegative randomization parameter that is constant throughout the trial 
(Hu and Zhang, 2004).  
Hu and Zhang show a law of the iterated logarithm of the doubly adaptive biased coin 
designs as well as several other designs (Wei, 1978). A law of the iterated logarithm is a 
standardization of the sum of a sequence of random variables that converges in probability but 
not almost surely.  By using martingale methods and the law of the iterated logarithm, they prove 
asymptotic normality of allocation proportions under some general conditions. This law is used 
to show asymptotic normality of the allocation proportion of the doubly adaptive biased coin (Hu 
and Zhang, 2004). Joint bivariate normality of the allocation proportion and target allocation are 
also shown upon standardization by   . The values in the covariance matrix for the multivariate 
normal distribution are determined by the same methods. 
The doubly adaptive biased coin can be used for either continuous or binary outcomes. 
The variance of the allocation proportion for the doubly adaptive biased coin is smaller than that 
for the randomized play the winner rule, especially when the allocation proportion is close to 0.5 
(Hu and Zhang, 2004).  
The coin can be generalized to the case of more than two treatment groups (Hu and 
Zhang, 2004). They prove results about the coin when the following conditions are considered.   
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1)  g(v, v) = v and g(x, y) - g(x, v) --> 0 as y -> v when x and y represent discrete densities 
2) gk(x,v) is Lipschitz continuous with an upper bound of 1 when x is a discrete density and xk is 
greater than vk. 
3) For any            and each k in (1, ..., K), there exists a constant   > 0 such that 
                for all x, y with x1'= 1, y1'= 1,           
 ,  
            
       
            
 >    uniformly in x, y 
with x1'= 1, y1'= 1,           . 
It is important to understand that condition 3 exists to avoid experimental bias. If all 
estimated target allocations for each of the k arms are not small, but the actual allocation to 
treatment k is very small, the probability of assigning the next treatment to k should not be too 
small in order to avoid large experimental bias. The authors claim that if the greater than sign is 
replaced by a less than sign then condition 3 follows from condition 2 (Hu and Zhang, 2004).  
If the Lipschitz continuity constant referred to in the conditions for the randomization 
function is less than 0.5, then the convergence of the actual allocation proportion to the vector of 
target allocation proportions is  of order                  and the convergence of the estimated 
target allocation vector is also of order                 Both of these convergences are almost 
sure.  
The asymptotic variance of the allocation proportion of the DABC is a decreasing 
function of the randomization exponent in the formula, regardless of the explicit form of the 
target allocation, as long as the conditions elaborated above are satisfied (Hu and Zhang, 2004). 
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Another design that was proposed after the doubly adaptive biased coin was the efficient 
randomized adaptive design (ERADE). This is design is a combination of Efron’s coin and the 
doubly adaptive biased coin. Let x be the actual allocation to treatment #1 in the trial,   be the 
estimated target allocation, and   be a parameter between zero and one. The ERADE assigns the 
next patient to treatment #1 with probability: 
    if x >  , 
   if x =  , 
                  if x <  . 
When the log odds ratio,  1 2 1 2log /( )p q q p , is of interest, the allocation to treatment #1 
that minimizes the asymptotic variance of the log odds ratio estimate is 
1 2 2 1 1 2 2/( )p q p q p q    (Ivanova, 2003). This allocation also minimizes the sample size 
required to achieve given power if testing is based on the log odds ratio. The allocation that 
minimizes the expected number of failures for a fixed variance of the estimated odds ratio is 
 2 2 1 2/p p p   . The allocation that yields the same power as equal allocation for 
testing the log odds ratio is 3 2 2 1 1 2 2/( )p q p q p q   . When 1 1 2 2min( , ) min( , )p q p q  
1 30.5      and any allocation inside the interval [0.5, 3
 ] yields higher or the same power for 
testing the log odds ratio. Similarly, when 1 1 2 2min( , ) min( , )p q p q  3 1
0.5   
 
and any 
allocation inside [ 3 ,0.5] yields higher or the same power than equal allocation. It happens that 
1i i    , i = 1, 2, 3.  
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The Neyman allocation, 1 = 1 1 1 1 2 2/ ( )p q p q p q , maximizes the power of treatment 
comparison under a Z test for a       when the sample size is fixed. It assigns more patients to 
the treatment with the larger variance, while the allocation 1  
does the opposite. Therefore, the 
allocation 1  is “ethical” (assigns more patients to the better treatment) when, for example, both 
treatments have success rates below 0.5. Let without loss of generality 1 2p p . When 
1 20.5 p p   any allocation inside the interval [0.5, 3 ] is a desirable allocation for testing H0: 
1 2 0p p   
as it yields higher or the same power and assigns more patients to the better 
treatment than equal allocation. The allocation 1  is “ethical” when both treatments have success 
rates higher than 0.5. It has been argued that response adaptive designs are most useful in trials 
with highly successful treatments (Ivanova and Rosenberger, 2001). Also in trials where it is 
most desirable to minimize the number of treatment failures, the treatment failure as often death; 
therefore we discuss the case of comparing treatments with 1 2 0.5p p   
in more detail. For 
1 2 0.5p p   any allocation inside the interval [0.5, 3 ] is a desirable allocation for testing the 
log odds ratio as it yields higher or the same power and assigns more patients to the better 
treatment than equal allocation.  
Historically, designing an allocation scheme for a clinical trial requires balancing a 
number of different factors. This includes the desire to assign patients to treatment that appears 
superior during the course of the trial, as well as to achieve higher power with such allocations as 
the Neyman allocation.          
 An early approach to assigning patients in this way was to flip a coin with probability 
equal to the estimated target allocation (Melfi and Page 2001). For example, under this approach, 
the next patient would be assigned to treatment #1 with probability                     in 
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the Neyman allocation. The authors show that the allocation to treatment #1 converges almost 
surely to the target allocation as well under this scheme. 
 Some take the view that randomization not only mitigates biases but is the basis for 
inference, and is therefore very important (Rosenberger and Lachin, 1993). The first approach,  
however, introduces positive correlation between the sequential treatment allocations, which can 
increase the variance of the allocation proportion and therefore decrease power.  
The Z test setup can be used to show that the size of the noncentrality parameter for the 
associated Chi squared distribution in the test corresponds to the power of the trial (Hu and 
Rosenberger, 2003). The authors use a power series expansion to show that the Neyman 
allocation maximizes this power. There are more complicated procedures that do as well, but 
what is necessary for these procedures to work is that the allocation proportion converge almost 
surely to constant. 
These results are also generalized to a multi-treatment clinical trial setting where the test 
is an omnibus test of whether any are different from the null. The authors also use simulations to 
show that the urn allocation has the smallest failure rate and noncentrality parameter, a second 
design (with allocation probability proportional to        ), has the next smallest of each, 
followed by the Neyman allocation with the highest power and highest failure rate.  
Among the response adaptive randomization procedures, Ivanova’s drop the loser rule 
has the most power, followed by the DABC. However, it is important to remember that the 
DABC can target more allocations than Ivanova’s rule. It has been shown that  there was an 
asymptotic lower bound on the variability of the allocation proportion (Hu, Rosenberger and 
Zhang, 2006). The authors compute the lower bound by multiplying the product of the partial 
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derivatives of the target allocation by the inverse of the Fisher information when the target 
allocation is achieved. Besides Ivanova’s drop the loser design, Zelen’s play the winner rule also 
achieves this lower bound (Hu, Rosenberger and Zhang, 2006). In the proof of the main result a 
sequence of independent random variables is created from the original sequence via an 
application of the Martingale central limit theorem. 
Some of the earliest statistical theory deals with trying to detect a linear relationship between 
a pair of random variables. However, often other relationships are of interest. Other attempts to 
capture these relationships statistically include CorGC (Delicado and Smrekar, 2009), mutual 
information (Breiman, 1968), and the Spearman rank correlation coefficient (Breiman, 1968). 
Mutual information is a way of assessing how close the relationship between two random 
variables is to independence. It is computed by taking the Kullback-Leibler divergence between 
the joint density and the product of the marginal densities. The Spearman correlation coefficient 
is based on the ranks of the data and is geared toward discovering a monotonic relationship. The 
CorGC is based on principal curves that are fit to the data.  As with any two methods, the 
principal curve has drawbacks. The latter two methods make some assumptions about the 
relationship in the first place, while mutual information is harder to implement in smaller 
samples when the form of the density must itself be estimated. 
In the middle of the last century (Renyi, 1959)  several axioms were proposed that a measure 
of dependence between two random variables defined on the same probability space must have. 
i) The measure should be defined for any pair of random variables (X,Y), neither of 
them being constant with probability 1.  
ii) The measure should be symmetric 
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iii) It should lie within [0,1] 
iv) It should equal zero only in the case of independence. 
v) It should equal one only in the case of strict dependence of the two random variables. 
vi) It should be invariant under functions of it two arguments that map the real line in a 
one to one way onto itself.  
vii) If the joint distribution is bivariate normal, then the function should be equal to the 
absolute value of the correlation coefficient. 
Later in the twentieth century several different dependence measures were proposed,, but not 
all of them satisfied these axioms. The CorGC satisfied axioms ii), iii), and vii), as well as 
curved based analogues of axioms i) and v) (Delicado and Smrekar, 2009). The method is best 
designed for arguments distributed along a curve with no noise. Local measures of linearity on 
the curve are defined and then they are aggregated to obtain global measures of dependence. 
Recently a new measure of dependence of random variables was proposed that was 
computationally straightforward and did not require any assumptions (Sekely and Rizzo, 2009). 
It could be used for both multivariate and univariate data. The approach requires the ratio of the 
product of mean absolute differences from the different group means. The formula follows from 
a theorem about characteristic functions and a complex trigonometric integral that is related to 
the gamma function. The statistic has a well defined null distribution in the case of independence 
which is consistent for any alternative. It can also be derived from the covariance determined by 
conditioning on independent Wiener processes, hence the name. The big strength of this statistic 
is that can detect any relationship between two possibly multivariate random variables. However, 
it has drawbacks of its own. When the statistic is calculated for two different pairs of random 
variables, it is not clear if the two different relationship strengths can be compared. In the case of 
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the Pearson correlation, the comparison would indicate the strength of the linear relationship. 
Another potential drawback to this method is that it does not reveal the actual nature of the 
relationship, just that one exists. 
It has also been shown on the machine learning side, that Reproducing Kernel Hilbert 
Space measures can be viewed as an extension of the distance covariance. 
Another method to search for patterns in large data sets that was recently introduced is 
called the MINE statistic (Reshef, et al. 2011). This statistic also has the ability to detect 
arbitrary relationships in data sets. Like the Brownian distance covariance, it is invariant under 
affine transformations. It is also a rank statistic and it is this property that is used for computing 
tables of p values. The authors compare the statistic to several other statistics used to find general 
relationships, including the Brownian Distance Covariance. They note that it is only their 
statistic that has the property of equitability between different relationships with the same 
amount of noise. What they mean by this is that if two data sets are generated by drawing values 
from two different mathematical functions at random and perturbing each of them with the same 
amount of symmetric normal noise, then the value of the MINE statistic will be very similar for 
these two data sets. The statistic relies on the concepts of mutual information mentioned earlier. 
It statistic can be computed in a series of steps.  
 First, a series of different grids is drawn over the data scatterplot. The grids increase in 
the number of cells, and each grid is selected using a greedy algorithm. The maximum size of the 
grid was chosen by the authors after some empirical evidence, to be the number of data points 
raised to the power of 0.6. For each grid, the mutual information of the induced discrete 
distribution is recorded and is divided by the maximum possible value of the mutual information 
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for the grid, given its dimensions. This maximum can be easily derived from the theoretical 
formula for mutual information. The maximum of this ratio across all grids that are investigated 
is called the MIC. A MINE statistic is a statistic that’s based on the MIC. These include ways to 
assess degrees of monotonicity or closeness to being a function. A larger MIC indicates a 
stronger relationship, and the grid that is retained from the calculation offer insight into what the 
explicit relationship is, which the Brownian distance covariance does not.   
 The MIC has certain desirable properties. First, in the case of statistical independence, it 
converges to zero in probability. Second, in the case of statistical dependence the statistic is 
bounded away from zero almost surely. Third, if the data are drawn from a noiseless functional 
relationship then the MIC converges to one. A property noticeably missing from this list is 
consistency: the authors do not show that the MIC converges to a number between zero and one 
in the case of noisy dependence. The Brownian Distance Covariance statistic, however, does 
have the property that it converges to its theoretical value in large samples. It has also been 
argued that the MINE statistic suffers from low power when the sample size is reasonable (200-
300) (Gorfine-Orgad, 2012). Kosorok (personal communication) also observed that the MINE 
can register sizable correlations for random noise in reasonable samples, suggesting that Type 1 
error may also be a problem in those samples as well. The MINE statistic is also not precisely 
equitable; it is a property that is established through simulation studies that are compare MINE to 
other methods.  
 One issue that is related to both the Brownian Distance Covariance and the MINE 
statistic is whether information about a change in the marginal mean of one variable with respect 
to the second can be extracted from information about the existence of a relationship. The same 
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can be said of the marginal variance. In survival analysis these questions are often more of 
interest than simply whether a relationship exists. 
The literature reveals several different issues that are longstanding in the statistical 
community. One of these is the attempts to minimize selection bias as well as other kinds of bias. 
Selection bias has been studied in allocation regimes that have a fixed target allocation and those 
that do not. However, one important question that until now remains unanswered is, what is the 
minimum amount of selection bias that one may have in a clinical trial with an arbitrary target 
allocation? This is one of the questions that we address with our research. An issue raised by 
higher order urn models is in what circumstances they would outperform methods such as DABC 
and ERADE in terms of power and resistance to selection bias. That is an issue that we are able 
to address. Another question that is raised by methods related to detecting nonlinear relationships 
is whether these methods can be adapted to censored data that is found in survival analysis. That 
is also one of the questions that we address. Also, it is important to consider the modification of 
new relationship detection methods to search for relationships between several different random 
variables. Another issue that is not addressed in the literature is what can be said about the 
distance covariance or MINE statistic between a pair of random variables given that the 
corresponding statistic between each random variable and a third random variable is already 
known. 
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CHAPTER 2: HIGHER ORDER RESPONSE ADAPTIVE URN DESIGNS FOR HIGHLY 
SUCCESSFUL TREATMENTS 
 
2.1 Introduction 
Consider the problem of comparing two treatments in a randomized clinical trial. An 
issue that is central to such a trial is balancing the ethical imperative to assign more patients to 
the better treatment with the need to have sufficient power to compare the treatments. Response 
adaptive designs change allocation away from equal allocation based on responses observed so 
far in the trial; see Hu and Ivanova, 2004, and Hu and Rosenberger, 2006, for review. Early 
response adaptive designs, generalized Pólya urn (Athreya and Karlin 1968; Zhang et a., 2006), 
the play-the-winner rule (Zelen, 1969) and the randomized play the winner rule (Wei and 
Durham, 1978) were developed for comparing treatments with binary outcomes to yield 
“ethical” allocation in the limit, that is, to assign more patients to the better treatment. Their 
limiting allocation, as well as the limiting allocation for the urn design of Ivanova (2003), though 
“ethical”, is not optimal with respect to maximizing power of the treatment comparison. In some 
cases, a trial with allocation proportion that is not optimal in terms of power requires many more 
subjects to achieve the same power than equal allocation. This can result in observing more 
failures in the trial than under equal allocation, therefore defeating the purpose of a response 
adaptive design to reduce the average number of failures in the trial. Other response adaptive 
designs such as  doubly adaptive biased coin designs (Eisele, 1994; Hu and Zhang, 2004), and 
the efficient randomized adaptive design (ERADE) (Hu, Zhang and He, 2009) can target any 
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desired allocation including the allocation that maximizes power.     
 An important metric of any allocation procedure is the amount of randomness it provides. 
In a deterministic procedure the next assignment can be predicted for sure if all previous 
assignments and outcomes, in case of response adaptive allocation, are known. On the other side 
of a spectrum is a fully randomized allocation procedure, an allocation via a fair coin, in case of 
equal allocation, or biased coin otherwise. We use entropy to measure randomness of the 
designs, a measure that has not been used before when response adaptive designs were 
compared. This allows making a fair comparison of adaptive procedures since deterministic 
procedures are more efficient in targeting the desired allocation. 
Hu and Rosenberger (2003) showed that the power of treatment comparison is closely related to 
the variability of the allocation proportion: the higher the variability the lower the power. The 
variability of the allocation proportion depends on the type of allocation procedure as well as on 
the allocation that the design targets and the amount of randomness it provides. The urn design 
of Ivanova (2003) yields the lowest variability as it achieves the lower bound of the asymptotic 
variance of the allocation proportion (Rosenberger and Hu, 2003; Hu, Rosenberger and Zhang, 
2006), so does the ERADE (Hu, Zhang and He, 2009). The doubly adaptive coin design achieves 
the lower bound only when the procedure is deterministic (Rosenberger and Hu, 2003). 
Randomness and the variability of the allocation proportion in the ERADE and the doubly 
adaptive coin design depends on the value of the design parameter. When several response 
adaptive designs that target the same allocation are compared, and their corresponding design 
parameters are set to provide the same amount of randomness, then the best  design is the one 
that has the lowest variability of the allocation proportion. Zhang et al. (2011) put the lowest 
variability urn design of Ivanova (2003) and other urn models into a general framework of 
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immigrated urn models. In this paper, we generalize the design of Ivanova (2003) in a different 
way by allowing the change in the urn composition to depend on several previous outcomes, not 
only the most recent outcome. This new generalization allows targeting a large spectrum of 
allocation proportions, including allocations that yield good power of treatment comparison. 
Since the design of Ivanova (2003) yields the lowest variability of the allocation proportion the 
new design has low variability as well and as the result has better power than competitors. The 
generalization, however, creates challenges in obtaining theoretical properties of the design since 
the new design can no longer be embedded into a family of stochastic processes unless 
multidimensional state space is considered.  
Our motivating example is the Comparison of Arixtra in Lower Limb Superficial Vein 
Thrombosis with Placebo (CALISTO) trial (Decousus et al., 2010). This was a randomized trial 
comparing a new drug Arixtra with placebo in patients with acute symptomatic thrombophlebitis 
of the lower limbs. The primary efficacy outcome was a composite of death from any cause or 
symptomatic pulmonary embolism or symptomatic deep-vein thrombosis or symptomatic 
extension to the saphenofemoral junction or symptomatic recurrence of superficial-vein 
thrombosis at day 47. The observed success probabilities were 99.1% in Arixtra arm and 94.1% 
on placebo. Similar success probabilities for placebo are often observed in other cardio-vascular 
trials. For example, 30-day mortality is a commonly used primary endpoint in trials comparing 
therapies for acute myocardial infarction, these trials yield around 93% - 95% non-failure rate 
(Hjalmarson et al., 1985; Tebbe et al., 1998). The incident mortalities are usually compared via 
log odds ratios. Response adaptive designs are beneficial for trials like these because they reduce 
the number of failures on average and increase power of treatment comparison, if the treatment is 
better than placebo, because when highly successful treatments are compared based on log odds 
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ratios or relative risk the power is maximized when more patients are assigned to the better 
treatment (Dette, 2004). 
In this paper in Section 2 we review possible target allocations for trials comparing two 
treatments. We introduce higher order urn designs in Section 3. We present the theoretical result 
for normally distributed outcomes in Section 4. Simulations results are described in Section 5. In 
Section 6 we re-design the CALISTO trial. Section 7 is a discussion section. 
 
2.2. Optimal allocations 
Consider the case where two treatments are compared. Let Ni(n) be the number of subjects 
assigned to treatment i, i = 1, 2, by the time a total of n subjects have been assigned, 
1 2( ) ( )N n N n n  . The allocation proportion to treatment 1 by the time n patients have been 
assigned is 1( ) /N n n . The optimal allocation proportion can be determined by using multiple-
objective optimality criteria (see Jennison and Turnbull, 2000, for more details). If treatment 
outcomes are binary from ( )iBernoulli p , 0 1ip  , 1i iq p  , i = 1, 2, the allocation proportion 
on treatment 1, 1 1 1 1 1 2 2/( )p q p q p q   , Neyman allocation, minimizes the variance of 
1 2
ˆ ˆp p . Alternatively, it minimizes the total sample size required to achieve given power if the 
Wald’s test statistic is used to test H0: 1 2 0p p  . The allocation that minimizes the expected 
number of failures for a fixed variance of the estimate of the parameter of interest or for fixed 
power (Rosenberger et al., 2001) is 2 1 1 2/( )p p p   . Another allocation to mention is 
3 1 1 1 1 2 2/( )p q p q p q   ; it yields the same power as equal allocation (see discussion of 3  in 
Baldi Antognini and Giovagnoli, 2010). When the log odds ratio,  1 2 1 2log /( )p q q p , is estimated 
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the three corresponding allocations are 1 2 2 1 1 2 2/( )p q p q p q   , 
 2 2 2 1 1 2 2/p q p q p q   , and 3   2 2 1 1 2 2/ ( )p q p q p q .  
Ivanova and Rosenberger (2001) noted that response adaptive designs are most 
advantageous in trials with highly successful treatments, or equivalently trials with low 
probability of a bad event occurring for the following two reasons. First, in such trials treatment 
failure is often death (Hjalmarson et al., 1985; Tebbe et al., 1998) or severe disability (Connor et 
al., 1994; Simoons et al., 2002; Wallentin et al., 2003) and therefore it is most desirable to 
minimize the number of treatment failures. Second, if treatments are compared based on log odds 
ratio, the allocation  that maximizes power,, allocation 1 , assigns more patients to the better 
treatment when both success probabilities are higher than 0.5.  In the case of highly successful 
treatments, the allocation 3  might be an even  better  target for a response adaptive design than 
the allocation 1  since it assigns even more patients to the better treatment and therefore further 
reduces the expected number of failures. For example, the optimal allocations for success 
probabilities 1 0.991p   
and 2 0.941p   observed in CALISTO trial are 1 0.717  , 2 0.869   
and 3 0.866  . The total number of failures observed in CALISTO trial was 101, 13 out of 
1502 in Arixtra arm and 88 out of 1500 in placebo arm. The allocation ratio 3 0.866   would 
have yielded 46 total failures out of 3002 patients on average if the true rates were equal to those 
observed in CALISTO trial, reducing the average number of failures by 55. For small sample 
sizes the limiting allocation 3  might not be reached, still, the trial most likely will result in an 
allocation somewhere in (0.5, 3 ], yielding better power and reduced number of failures 
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compared to equal allocation. Therefore 3  is an ideal target allocation in trials with highly 
successful treatments. 
 
2.3. Higher order urn designs for binary outcomes  
2.3.1. The second order urn design for binary outcomes
 
We introduce the second order urn design to create an urn design that focuses on variability of 
the estimated treatment effect rather than the mean. As a  result the new design targets allocation 
proportions that are optimal or nearly optimal in terms of power, such as allocation 3 . Also, by 
modifying a low variability design from Ivanova (2003), we obtain another low variability 
design and therefore we expect the new design to have good power compared to competitors as 
variability affects power negatively (Hu and Rosenberger 2003).. The design is defined as 
follows:  
Second order urn design. The urn contains balls of three types. Balls of types 1 and 2 
represent the two treatments.  Balls of type 0 are called immigration balls. Initially the urn 
contains 2b + a balls; b balls of each treatment type and a, a > 0, immigration balls. Assume that 
j patients have been treated so far, with at least one patient assigned to each treatment. If the jth 
patient was assigned to treatment i, let ( )( )i
i
N jX  be this patient’s outcome. A ball is drawn from the 
urn at random. If the ball is of type 0, i.e., an immigration ball, no subjects are assigned to 
treatment, and the ball is returned to the urn together with 2 additional balls, one of each 
treatment type. If a ball corresponding to treatment i is drawn, i = 1, 2, the next subject is 
assigned to treatment i and an outcome ( )( )i
i
N jX  is observed. If 
( ) ( )
( ) ( ) 1i i
i i
N j N jX X  , where 
( )
( ) 1i
i
N jX   is 
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the outcome of the previous subject assigned to treatment i, the ball is not returned. Otherwise, 
the ball is returned to the urn.  
In the urn design of Ivanova (2003) the ball is not returned to the urn if there is a failure 
on the corresponding treatment. In the second order urn design the ball is not returned to the urn 
if the two most recent responses on the treatment are different, thus changing the urn 
composition according to the variability rather than the actual  outcome. In this urn design the 
ball is not returned if outcomes are different, which increases the allocation to the treatment with 
smaller variance.  
2.3.2. Limiting allocation proportion and variability of the second order urn design 
When a response adaptive design is investigated, what is most important is the distribution of the 
proportion of patients assigned to each treatment, specifically the limiting distribution as the 
number of patients tends to infinity. To obtain this distribution for the second order urn design, 
we use the technique of embedding the design into a family of continuous time stochastic 
processes (Ivanova, 2003; Ivanova, 2006). First, we note that the design can be described by 
using the notion of continuous time (see Ivanova, 2003 and Ivanova, 2006, for more details), 
which is a useful mathematical construct not related to the real time in the medical experiment. 
Let Zi(t) be the number of balls of type i at time t, Ui(t) be the number of draws of a ball of type i 
followed by a success on treatment i, and Yi(t) be the number of draws of a ball of type i 
followed by a failure on treatment i, so that the number of trials on the ith treatment, i = 1, 2, is 
Ni(t) = Ui(t) + Yi(t). Let I(t), the common immigration process, be the number of draws of balls of 
type 0, immigration balls. By construction Zi(t) = Zi(0) + I(t) - Yi(t). The number of trials Ni(t) is 
what interests us most, and the number of balls in the urn, Zi(t), is the quantity that defines this 
process. This technique has already been discussed in the stochastic processes literature. Ivanova 
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et al. (2000) extended the technique from Cox and Miller (1965, p. 265) to obtain the differential 
equation for the joint probability generating functions. To describe the behavior of Ni(t), we will 
obtain its joint generating function with the number of balls in the urn, Zi(t), 
 ( ) ( )( )( , , ) i iZ t N tiG t z w E z w . Since the two most recent responses are used, consider the 
generating function ( )
0 ( , , )
iG t z w  describing the behavior of the process corresponding to 
treatment i when the preceding state was 0, the penultimate on treatment i was a success, and the 
generating function ( )
1 ( , , )
iG t z w  describing the behavior of the process when the preceding state 
is 1, the penultimate response on treatment i was a failure, with 
( ) ( ) ( )
0 1( , , ) ( , , ) ( , , )
i i iG t z w G t z w G t z w  . Using backward equations, the following system of 
equations is obtained (see Appendix I for more details): 
( ) ( ) ( )
( )0 0 1
0
( ) ( ) ( )
( )1 1 0
1
( , , ) ( , , ) ( , , )
( ) ( 1) ( , , )
( , , ) ( , , ) ( , , )
( ) ( 1) ( , , )
i i i
i
i i
i i i
i
i i
G t z w G t z w G t z w
q wz z q w a z G t z w
t z z
G t z w G t z w G t z w
p wz z p w a z G t z w
t z z
  
    
  
  
    
  
 .      (1) 
Initial and boundary conditions are ( )
0 (0, , )
i
iG z w q z , 
( )
1 (0, , )
i
iG z w p z , and 
( )( ,1,1) 1iG t  , i = 
1, 2, with t  0, |z|  1, and |w|  1. 
We are interested in the limiting allocation proportion for the urn  plim ( ) /n iN n n , 
where plim denotes convergence in probability. Ivanova (2003) showed that the limiting 
proportion can be computed by first obtaining 
 
 ( )
1
log ( ,1, )
lim ( ) lim
i
t i t
w
G t w
E N t
w
 




. 
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It might not be possible to obtain the closed form solution of the system of equations (1) except 
for special cases, however lim ( ( ) / )t iE N t t  can be obtained by taking logs and then 
differentiating functions in the equations (1). We get lim ( ( ) / ) / (2 )t i i iE N t t a p q  . Using 
Theorems 3.1 and 3.2 from Ivanova (2000),  
  1 1 2 21
1 1 2 2 1 1 2 2
/ (2 )
p lim ( ) /
/ (2 ) / (2 )
n
a p q p q
N n n
a p q a p q p q p q
  
 
, 
which is 3 .  
The variability can be assessed by computing  
 
 
 
1 2
( )
1
(1,2)
1 2 1 2
1 2 1
log ( ,1, )
( ) ,
( ), ( ) log ( ,1, , ) ,
i
i
w
w w
d G t wd
var N t w
dw dw
cov N t N t G t w w
w w

 
 
 
  
 

 
 
where (1,2)
1 2( ,1, , )G t w w  is a joint function for N1(t) and N2(t) (see Ivanova, 2006, for  details). It 
was not possible to obtain the closed form expressions for  1( )var N t ,  2( )var N t  and 
 1 2( ), ( )cov N t N t  for given t and as t so we resorted to numerical computations.      
2.3.3. Higher order urn designs for binary outcomes 
In Section 3.1 we introduced the design that is an extension of the low variability design from 
Ivanova (2003) and uses two most recent responses instead of one response as in the original 
Ivanova design. In this section we extend the design further by using three or more responses. 
This extension creates designs that target an even wider range of allocation proportions and 
converge faster than the second order urn design while keeping variability low as before.  
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To describe this extension we first note that the second order design defined in Section 
3.1 can be alternatively defined using the estimate of success probability obtained from the two 
most recent observations. The estimate  ( ) ( )( ) ( ) 1ˆ / 2i i
i i
i N j N jp X X   , i =1, 2, can take on three 
possible values 0, 1/2 and 1. The ball of type i is not returned if ˆ 0.5ip  . Similarly, in the kth 
order urn design, the estimate of success rate is based on the k most recent responses: 
( )
( ) 11
ˆ /
i
k i
i N j mm
p X k  . Let an integer  be such that 2k  , if k is even, or 2 1k   , if k is 
odd. Consider the kth order design where the ball is not returned if ˆ /ip k  or ˆ 1 /ip k  , 
that is, the ball is not returned if the estimate of success rate is the closest possible to 0.5. The 
probability of not returning the ball is k
i i iQ C p q
 
  if 2k  , or 
1 1k k
i i i i iQ C p q C p q
   
 
     
( )k ki i i i i iC p q p q C p q
   
    if 2 1k   . Here 
kC   !/ !( )!k k   is a binomial coefficient with 
0kC  , if  < 0 or  > k. The limiting allocation proportion for this urn design (Ivanova, 2003) 
is equal to 2 1 2/( )Q Q Q 2 2 1 1 2 2/( ) ( )p q p q p q
          . For example, when k = 3 the limiting 
allocation proportion is 2 2 1 1 2 2 3(1) / ( )p q p q p q    , when k = 4, the allocation is 
2 2 2 2 2 2
2 2 1 1 2 2(2) /( )p q p q p q   . For 1 2p p  and   , ( ) ( )    , therefore for all  > 1 ( )   is 
closer to 1 than 3(1)  . Allocations ( )   for  > 1 might be desirable for trials with the goal 
of selecting the best treatment, however, as was discussed in Section 2, the power under 
allocations ( )   with  > 1 is lower than under 3  or under equal allocation.    
With the use of a biased coin the kth order urn design can be made to target the desirable 
allocation 3 . Consider a kth order urn design, k = 4, 5…, where the ball is not returned if 
ˆ /ip m k  or ˆ 1 /ip m k  , m = 1,…, k -1, and a biased coin with probability of heads equal to 
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 2 21 1/k k k km mC C C C     lands heads. To compute the limiting allocation proportion for this design we 
first compute the probability of not returning the ball  
21 1
2 1 11
12 2
1 11 1
2
2 ' 2 ' 2
2 2 2
01 1 1
( ) .
k k kk k
k m k m k m k mm
i m i i i i m i ik k k
m mm
k k kk
k m k m k
i i m i i i i i i i ik k k
m
C C C
Q C p q p q C p q
C C C
C C C
p q C p q p q p q p q
C C C
 
 
  
  
 
    
 
  

   
  
  
 
   
 

 
Therefore the limiting allocation is equal to 2 1 2/( )Q Q Q 2 2 1 1 2 2 3/( )p q p q p q    . For example, 
when k = 4, the possible values for ˆ ip  are 0, 1/4, 1/2, 3/4, and 1. According to the design 
described above, the ball is not returned if ˆ 1/ 2ip  ; or if ˆ 1/ 4,3 / 4ip   and a biased coin with 
the probability of heads equal to 3/4 lands heads. When k = 5, the ball is not returned if 
ˆ 2 / 5,3 / 5ip  ; or if ˆ 1/ 5,4 / 5ip   and a biased coin with the probability of heads equal to 2/3 
lands heads. 
2.4. Higher order urn designs for normally distributed outcomes 
In this section we define the kth order urn design for continuous outcomes and prove a result 
about its limiting allocation. As response adaptive designs are mostly advantageous when 
treatments with binary outcomes are compared (unless the variances of continuous responses in 
the two arms are very different), the goal of this section is to provide insights into how to 
construct higher order urn designs for binary outcomes that yield good power of treatment 
comparison.  
Let responses to the two treatments coming from 2( , )i iN   , and ˆi  be the maximum 
likelihood estimate of i , i = 1, 2. The allocation proportion that minimizes the variance of 
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1 2
ˆ ˆ   is the Neyman allocation 
1 1 2/( )Ney     . Assume that outcomes of treatment i 
come from 2( , )i iN    and let 
2ˆ
i  be the estimate of the variance based on the k most recent 
observations on treatment i, defined as  
 
2
2 ( ) ( )
( ) 1 ( ) 1
1 1
ˆ /( 1),  where / .
i i
k k
i i
i N j m N j m
m m
X X k X X k    
 
      
Then, the ball is not returned to the urn if 2ˆ
i   for some . The following theorem 
characterizes the limiting distribution.  
Theorem. As   , the limiting allocation proportion for the kth order urn design, 1k  ,  with 
normally distributed outcomes tends to 1 1 2/( )     .  
Proof. The distribution of 2 2ˆ( 1) /i ik    is chi-squared with degrees of freedom 1df k  .  Let F 
be the cumulative distribution function of chi-squared distribution with 1df k  , and f be its 
density function. The probability of not returning the ball is  2( 1) / iF k    and the limiting 
proportion is (Ivanova, 2003) 
 
   
2
11
2 20
1 2
( 1) /( )
plim lim
( 1) / ( 1) /n
F kN n
n F k F k
 
   


  
. 
Now it follows from L’Hôpital’s Rule that: 
 
   
2 2 2
1 1 1 2
2 2 2 22 20 0
1 1 2 2 1 21 2
( 1) / ( / ) /
lim lim
( / ) / ( / ) /( 1) / ( 1) /
F k f
f fF k F k 
     
           

 
   
, 
since 
/ 2 1 / 2( ) k xf x x e  . 
Hence, if a sufficiently small   is chosen, the limiting allocation for the kth order urn 
design with normal outcomes and any k >1 will be close to Neyman allocation. This result gives 
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basis to the general strategy of constructing higher order urn designs for binary outcomes 
described  in previous sections.  
 
2.5. Comparison with competing designs 
In this section we compare the new urn designs with the doubly adaptive biased coin design (Hu 
and Zhang, 2004) and the efficient randomized adaptive design (Hu, Zhang and He, 2009). 
The doubly adaptive biased coin design (Hu and Zhang 2004) allocates patient j to 
treatment i with probability ˆ( ( ) /( 1), )ig N j j  , where ˆ  is the target proportion estimated from 
the data. We use the choice of g from Hu and Zhang (2004):  
 
( / )
( , ) ,
( / ) (1 ) (1 ) /(1 )
(0, ) 1,
(1, ) 0.
x
g x
x x
g
g


 

   



   


 
Here  is a design parameter controlling the amount of randomization in the design. Let 
1 2( , )p p  be the target allocation proportion as a function of p1 and p2, for example, 
 1 2 2 2 1 1 2 2( , ) /p p p q p q p q    for inverse Neyman allocation. Hu and Zhang (2004) give 
the following formula for the asymptotic variance, 2 , of 1( ) /N n n  
 
 
2
2 21
2
2
1 1 2 1 2
2 2
2 1 2 1 1 1 2 2 2
2
1 1 2 2 1 2
2 1
, where
1 2 1 2
( , ) 1 ( , )  and
( , ) ( , )
.
( , ) 1 ( , )
p p p p
p p p q p p p q
p p p p p p

 
 
  
 

 

 
 
 
    
    
     
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When 0  , the design is fully randomized, and the variance is 2 2
1 22  ;  when     the 
design is deterministic, the variance is 2
2  and is equal to the lower bound of the asymptotic 
variance. Hu and Rosenberger (2005) recommended using the design with 2  . 
 The ERADE (Hu, Zhang and He, 2009) is a generalization of Efron’s coin which attains 
the lower bound of the asymptotic variance and can target any desirable allocation. The ERADE 
requires specifying a design parameter π, 0 1  , that reflects the degree of randomization, 
with larger values of π corresponding to more randomization and variability. The design is 
defined as follows. As before, ˆ  is the estimated target allocation for treatment 1. Then the next 
patient is assigned to treatment 1 with probability ˆ  if the actual allocation to treatment 1 
exceeds ˆ ; with probability ˆ  if the two estimated allocations are equal; with probability 
ˆ1 (1 )    if the actual allocation exceeds the estimated target allocation. Hu, Zhang and He 
(2009) studied the choice π and found that the simulated results of π = 1/8 and 1/4 were very 
similar to the results of π = 1/2 in terms of allocation proportion and its variability, and the 
ERADE with π = 3/4 has a slightly larger variability than others. They recommended using π in 
[0.4, 0.7]. Since the ERADE with π = 0.5 performed very similar to lower values of ERADE we 
used the ERADE with π = 0.5.  
 We compared designs based on variability of allocation proportion and randomness. 
Randomness was quantified by summing entropy of the allocation distribution for each 
assignment, 
1
log( )
N
j j
j
 

 , where j  is the probability of being assigned to treatment 1 after (j – 
1) patients have been assigned. For a given p1 and p2, the sample size, N, used for entropy 
calculations was that which yields 80% power with a two-sided type I error rate of 0.05 for 
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testing based on the log odds ratio. For the adaptively biased coin design 
1
ˆ( ( ) /( 1), )j g N j j   . 
In the case of the third order urn design, 
j  is equal to 
1
1 1 2
0 0
( ( ) ) ( ( ) ( ) 1 2 )
m
m k
z j m z j z j k


 
 
    
 
  , where ( )iz j  is the number of balls of type j in the 
urn right after the most recent treatment (non-immigration) ball was chosen, and the sum is over 
the number of immigration balls m to be drawn before a treatment ball is drawn. The product in 
the denominator is the probability that m - 1 immigration balls are chosen before ( )iz j  is finally 
chosen. We have not been able to obtain a closed form for the sum. Noting that that the sum of 
all terms after the mth term is less than the mth term (see Appendix II) it is easy to obtain the 
numerical value for the sum with any degree of accuracy. We computed the sum within 10
-14
 of 
the true value. 
First, we compare the asymptotic variance of the second and third order urn designs with 
the lower bound of the asymptotic variance of designs that target 3  and the asymptotic variance 
of the doubly adaptive biased coin design with 2  . Fig. 1 displays the asymptotic variances 
for 2 0.90p   and 1p  in [0.90, 0.99]. Even though the design from Ivanova (2003) achieves the 
lower bound of the asymptotic variance, the higher order urn designs do not, but their variances 
are very close to the lower bound and are significantly smaller than those of the biased coin 
design with 2  .  
 Second, we compared the designs for sample sizes required to achieve 80% power for 
treatment comparison if equal allocation was used. We compared the second and third order urn 
designs to the adaptively biased coin design with 2   and ERADE with π = 0.5 for values of p1 
and p2 greater than 0.5 based on the variance of the allocation proportion and on the amount of 
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randomness the designs provide. The regions of (p1, p2) sample space where the third order urn 
design has higher entropy, which is more desirable, are marked with vertical lines in Fig. 2. 
Elements of (p1,p2) space where the asymptotic variance for the third order urn design was 
smaller marked with horizontal lines in Fig. 2. In Section 2 we proposed 3  as the target 
allocation in a trial where treatment comparison is based on log odds ratio. The first row of Fig. 2 
shows the comparison with the adaptively biased coin design and the ERADE targeting 3 , the 
second row targeting 1 . Fig. 2 shows that the third order urn design performs well against the 
adaptively biased coin design and the ERADE targeting 3  in about half of the 2-dimensional 
region of (p1, p2). When the coin design and the ERADE target 1  the region where the new 
design is better is smaller, however, the advantage of the proposed design still holds for trials 
where highly successful treatments are compared.  
 
2.6. Example: re-designing CALISTO trial 
The proposed approach is illustrated by re-designing the CALISTO trial (Decousus et al., 2010). 
The total sample size in the trial was 3002 patients with 1502 patients assigned to Arixtra and 
1500 to placebo. The sample size of 3000 was chosen because it yields the power of 87% to 
detect a 2 percentage point absolute increase in incidence of events at the two-sided 0.05 level of 
significance using Fisher’s exact test, provided the incidence in the placebo group is no greater 
than 2%. Observed success probabilities were 1 0.991p   in the Arixtra arm and 2 0.941p   in 
placebo arm. Corresponding optimal allocations are 1 0.717  , which  minimizes the sample 
size given power, and 2 0.869  , which minimizes the expected number of failures given 
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power. Our proposed urn design targets 3 0.866  , the allocation that yields the same power as 
equal allocation by less treatment failures. For the success probabilities in CALISTO trial both 
the coin design and the ERADE perform better when targeting 1 , therefore we describe 
simulation results for these two designs for 1  target only. To redesign the CALISTO trial we 
first found the values of parameters   in the coin design and π in the ERADE design that yield 
the same randomness, measured by the total entropy, as the third order urn design. These 
parameters were 0   for the coin design and π = 0.28 for the ERADE. Then trials with 
assignments by the coin design and the ERADE were simulated. Results are presented based on 
5000 simulated trials. Simulation study was repeated with recommended values 2   and π = 
0.5 yielding similar conclusions. To simulate CALISTO trial we resampled from CALISTO data 
knowing that 13 out of 1502 failures were observed in Arixtra arm and 88 out of 1500 in placebo 
arm. Results when data were simulated from Bernoulli distribution with success probabilities 
1 0.991p   and 2 0.941p   
were very similar. If equal allocation is used and true probabilities 
are 1 0.991p   and 2 0.941p  , 536 subjects total are required to achieve 90% power with two-
sided test with the type I error rate of 0.05. As the sample size in CALISTO trial was much 
larger than needed we re-designed the trial as a two-stage trial with 1500 patients in each stage 
with the Pocock boundary (Pocock, 1977) to allow stopping early for efficacy. In fact, all trials 
were stopped for efficacy after 1500 patients. The average number of failures and the 5th and 
95th percentiles were 33 (25, 42) for the coin design, 34 (28, 41) for ERADE, 30 (26, 34) for the 
urn design and 50 (43, 59) for equal allocation. All response adaptive designs dramatically 
reduced the total expected failures with the new urn design yielding the smallest number of 
failures.  
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 Fig. 3 shows power curves in the informative region of total sample sizes, between 300 
and 600, for the third order urn design, the ERADE, and equal allocation. Power for the 
adaptively biased coin design is inferior and is not shown. As seen from Fig. 3, the proposed urn 
design has better power than equal allocation and the ERADE. Better power for the urn design is 
the result of low variability of the allocation proportion (Fig. 4). The average allocation 
proportion and its 25th and 75th percentiles (Fig. 4) show that the allocation proportion of the 
doubly adaptive coin design and the ERADE converges to the limiting proportion quickly, but 
that the variability of the allocation proportion is high. For example, for the total sample size of 
300, the allocation proportion in 10% of the trials is 90:10 or more extreme when the target is, in 
fact, 1 0.717  . This makes the design more sensitive to time trends and lower in power when 
multiple interim analyses are performed. Though the urn design converges slower, it is far less 
variable. 
 We also performed simulations with delayed response. As shown by Bai, Hu and 
Rosenberger (2002) the asymptotic properties of response adaptive designs under delay in 
outcome are the same as without a delay unless the delay is substantial and as long as adaptations 
are done frequently. We assumed that the data from the first patient was only available when the 
kth patient was enrolled, the data from the second patient was available when the (k+1) patient 
was enrolled etc. For example, if k ≥ 1500 in a trial with 1500 patients total, no data are available 
to modify the allocation proportion. A delay with k = 500 yielded 39, 39 and 38 failures on 
average for the coin design, the ERADE and the urn design with fewer failures observed on 
average than 50 failures under equal allocation. Significant delay of k = 1000 in a trial of 1500 
yielded 44, 44 and 45 failures on average for the three adaptive designs, only slightly fewer 
failures than under equal allocation with faster converging coin and ERADE designs now 
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performing better than the urn design. Note that if the adaptations of the allocation proportion are 
only performed once or twice during the trial, the proposed urn design is not suitable and the 
adaptively biased coin or the ERADE should be used. Both the coin design and the ERADE 
estimate the success probabilities using all available data and compute the desirable allocation 
proportion.  
 
2.7. Conclusions 
The doubly adaptively biased coin design and ERADE estimate the target allocation from the 
data and therefore can target any desired allocation proportion. Both designs converge rapidly to 
the target, however, the variability of the allocation proportion is high as well. The proposed 
higher order urn designs converge to the target allocation more slowly, however, are far less 
variable. In the example considered, the third order urn design does not result in extreme 
allocations and yields higher power than the doubly adaptive coin design, the ERADE and equal 
allocation. Another advantage of the proposed urn designs is that one does not have to know the 
most recent estimates of the treatments’ success probabilities 1p  and 2p . For the third order urn 
design, for example, one only needs to know if there were any failures among the most recent 3 
responses. Therefore, if data used for a recent adaptation are revealed, an investigator will not 
know the most recent estimates of 1p  and 2p .  
In the CALISTO trial example where two highly successful treatments were compared, 
all three response adaptive designs yielded substantial savings in failures compared to equal 
allocation. The proposed third order urn design and the ERADE resulted in similar or better 
power than equal allocation. Therefore, it is worth considering response adaptive designs as a 
design option for trials with highly successful treatments.  
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Figure 2.1. The asymptotic variance. Consider the second order urn design (dashed line), the 
third order urn design (dotted line) and the doubly adaptive biased coin design with parameters  
= 2 (upper solid line) and  =  (lower solid line). Success rate p2 = 0.9. 
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Figure 2.2. Range of success probabilities 1p  and 2p . When third order urn design has smaller 
asymptotic variance (horizontal lines) and higher entropy (vertical lines) than the doubly 
adaptive coin design with  = 2 (left panel) or ERADE with π = 0.5 (right panel). The diagonal 
line is the boundary of the sample space. The first row is for the coin design and ERADE 
targeting 3 , the second for 1 . 
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Figure 2.3. Power for the CALISTO trial. Consider 1 0.991p   and 2 0.941p   for third order 
urn design (solid line), the equal allocation (dotted-dashed line) and the ERADE with π  = 0.28 
targeting 1  (dotted line). 
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Figure 2.4. Allocation proportion and quantiles. The allocation proportion and its 25th and 75th 
percentiles for the trial with 1 0.991p   and 2 0.941p   for third order urn design (solid lines), 
the doubly adaptive coin design with  = 2 (dashed lines), and ERADE with π = 0.5 (dotted lines) 
plotted against the sample size. 
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CHAPTER 3: THE PROPERTIES OF ENTROPY AS A MEASURE OF RANDOMNESS IN 
THE CLINICAL TRIAL 
 
3.1. Introduction 
The interpretation of between-group comparisons in a clinical trial is facilitated by the 
creation of treatment groups that are similar to each other in baseline composition. Selection bias 
is a major impediment to baseline similarity of treatment groups especially in unmasked clinical 
trials. Selection bias occurs when expected responders are enrolled or denied enrollment based 
on the knowledge of treatment to be allocated next (Blackwell and Hodges, 1957), and how 
healthy the patients are. To minimize selection bias one needs to minimize predictability of 
future allocations based on past ones. One way to measure predictability is to define a reasonable 
guessing strategy and then compute the expected number of correctly predicted treatment 
assignments. Allocation procedures that minimize selection bias against various guessing 
strategies have been identified (Blackwell and Hodges, 1975; Stigler, 1969). One drawback to 
this approach is that it is somewhat arbitrary, because the expected value is just one measure of a 
distribution. Also, this requires assumptions about the distribution of healthiness in the patient 
population, which is generally difficult to evaluate. Finally, in a clinical trial where a response 
adaptive randomization design is used, it is not clear what the best guessing strategy for the 
investigator is, and thus it is not clear how to calculate bias.     
 A canonical way to measure predictability is to quantify the amount of information the 
investigator has about the next treatment assignment, given that certain previous treatment 
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assignments are known. This approach relies on information theory, specifically, Claude 
Shannon’s definition of entropy (Shannon 1959), which quantifies the amount of information 
observer has about the values a random variable may take. The greater the entropy, the less 
information the observer has. The formula for entropy of a discrete probability distribution 
taking on k values (which is the type of distribution the treatment assignment random variable 
will have) is  
1
log( )
k
i i
i
p p

 , 
where there are k different possible treatments, and pi is the probability of the ith
 
treatment being 
assigned given some prior knowledge about the trial. Entropy can range from zero, when the 
next treatment assignment is certain, to log(k), when each of the k treatments are equally likely. 
This maximum value is well known and can be found using Lagrange multipliers. This definition 
of information is very well established in the statistical literature because it has certain desirable 
properties, which we will not discuss here. Clearly we want the entropy of an allocation scheme 
to be large, because that would mean that the next treatment assignment is less predictable. 
Entropy has appeared in the clinical trials literature before, but has not been used to quantify the 
overall randomness of the trial. The first application was minimizing imbalance in a trial where 
there were several stratification factors (Klotz, 1978). The author proposed assigning the next 
treatment so as to minimize the entropy of each treatment assignment with respect to a constraint 
that is a function of the imbalance. However, the average entropy over the whole trial and how to 
maximize it was not discussed. Ball et al. (1993) measured treatment assignment uncertainty by 
entropy and used entropy as a penalty in an objective function that combined the precision of 
estimation of parameters of interest in a clinical trial. In the objective function, the entropy was 
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multiplied by a penalty factor that was essentially arbitrary. In contrast, our approach to entropy 
first optimizes the power and then optimizes the entropy subject to that constraint, and there are 
no arbitrary parameters. Atkinson (2002) used the idea of Ball et al. (1993) to create allocation 
design that balances randomness and inference. A more recent paper (Piantadosi, 2005) used 
entropy as a way of quantifying uncertainty about the treatment effect in a small trial, but it did 
not explore the concept of using entropy to quantify prior knowledge about upcoming treatments 
as related to bias. This paper also did not consider trials of arbitrary size. 
 In Section 2 we develop notation and define the important concepts. In Section 3 we state 
the main results of our paper. In Section 4 we consider several randomization designs and 
response adaptive randomization designs to illustrate theoretical results from Section 3.  Section 
5 is the discussion section.  
 
3.2. Notation  
Consider a clinical trial with treatments “A” and “B” where the outcome is measured as either 
success or failure. Let the binary sequence ( ) 1 2, , , nX X X 
n
X  denote the sequence of 
treatment assignments for a trial of length n. One example could be 
(4) , , ,A B A BX . We 
assume that all previous treatment assignments may be known. Let the binary sequence 
( )
1 2, , , nY Y Y 
n
Y  denote the sequence of outcomes, where “0” represents a failure and “1” 
represents a success, e.g. 
(4) 0,1,1,0Y . We assume further that for any j, j = 1,.., n, 
 Pr 1|j j AY X A p    and  Pr 1|j j BY X B p   . The goal of the trial is to gain information 
about unknown Ap  and Bp . By the trial data of length n, 
( )n
D  we simply mean 
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 ( ) ( ){ , }.  
nn n
D X Y For a given trial of length n let , n AN  denote the number of treatment 
assignments to A. We define the allocation proportion as 
, /n AN n . If
   1 1
Pr | , () ( )nX A f f
   
 
n n
D  D  then we say f() is a treatment allocation function for the trial. 
By a trial of length n, ( )nT , we mean  ( ) { , , , ()}A Bp p f
nn
T D   . Here 
 n
D  is the random part of 
the trial. Each 
( )n
T  has a well defined probability    Pr( ) Pr( | , , ())A Bp p f
n n
T D  . Note that 
 1
Pr( | , ())nX A f


n
D  is a random variable that depends only 
 1n
D  and ()f , while  Pr nX A  
is fixed number that is a function of Ap , Bp  and f(). Let the trial set 
( )n
S  be defined as: 
  ( )  all possible  nnS T for a fixed triple ( , , ())BAp p f . 
Note   
( ) ( )
Pr 1


n n
n
T S
T  and 
( ) 22n nS  . 
Let the trial sequence C be defined as the collection of 
(1) (2){ , , }S S ; it is countably 
infinite. We say the trial sequence targets allocation proportion   if for any 0   and 0   
there is an  m N  such that n m  implies  
  
( ) ( )
,   ( , ) Pr 1n A
N
I
n
    

 
     
 

n n
n
T S
T . 
where ()I  is an indicator function. Not all clinical trial sequences target an allocation.  
When C targets an allocation   we define the asymptotic variance as 
, lim ( / )n A
n
Var n N n 

 
  , where the variance is taken over all possible trials in 
( )n
S . This limit 
may be zero and also it may not exist. This definition of asymptotic variance coincides with that 
used in the literature (Hu and Zhang, 2004). 
We consider the random variable 
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  1Pr | , ()n nP X A f  nD  . 
Since the number of trials of length n is always finite, nP  is a discrete random variable with 
support on [0, 1]. Its density can be computed as follows 
    
( 1) ( 1)
1 ( 1)Pr | , () Pr( )
n
n n
n n
P n
T S
f p I X A D f p T
 
 

   
  , 
 Note that this is distinct from: 
    
( 1) ( 1)
1 1
Pr | , () Pr  Pr( ).n nX A f X A
 
 

   
 
n n
n n
T S
D T  
This second quantity is just the unconditional probability that the nth patient receives treatment 
A, which is not random. The density of Pn, ( ) 
nP
f p , is the marginal distribution of the conditional 
probabilities. We now present several examples of nP . Histograms for the three examples are 
presented in Figure 2.1. 
Example 1, biased coin: Consider a clinical trial allocation scheme that consists of 
assigning patient n to a treatment by flipping a coin that has probability   of coming up heads. 
If the coin comes up heads, the patient receives treatment A; if the coin comes up tails, the 
patient receives treatment B. While the allocation proportion to treatment A may vary during the 
trial, nP  is the same for each patient – just a point mass at  . Figure 2.1 shows the density 
function for 0.5  , the fair coin design. 
Example 2, two-sequence assignment: A fair coin is flipped. If it lands heads, then the 
trial proceeds as A,B,A,B,A,B… If it lands tails, then the trial proceeds as B,A,B,A,B,A… In this 
case, the random variable nP  takes on the values 0 and 1. For each patient, nP  is 0 with 
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probability 0.5, and 1 with probability 0.5. This is because there are exactly two equally likely 
trials of length n, and the allocation probability for the nth patient is completely determined by 
that of the first n-1 patients, so the probability conditional on the assignments of the first n-1 is 
either 0 or 1. However, the (unconditional) probability that the nth patient is assigned treatment 
A is simply 0.5. Thus, this example illustrates the difference between this probability and nP . 
Example 3, adaptive biased coin: Consider this allocation function, which targets the 
allocation proportion 0.5: 
       1 1 1 , Pr | , ()  1 / ( 1)n n AX A f f N n      n nD D  
1 current  allocation proportion. 
Note that for a clinical trial set with this allocation function, Pr(
( )n
X ) does not depend on Ap  
and Bp . For this design, we see that the allocation proportion , /n AN n  and nP  both vary with n. 
The probability /nP a n , for some   (0,1,...,  ) a n  and nPf  is larger when a is closer to / 2n .  
Now we consider the question of calculating the entropy for the clinical trial.  If nP p  
then we define the random variable: 
     log 1 log 1nH p p p p       . 
Define the asymptotic mean entropy as: 
 
1 1
1 1
lim lim   
n n
n n
i i
i iE H E H
n n  
 
 
 
  . 
The asymptotic mean entropy is thus a property of the trial sequence C, not trial sets ( )nS or trials 
( )n
T . 
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3.3. Results 
Our results describe the relationship between the distribution of nP  and the entropy of the trial 
sequence, and also include a result about the variance of nP  for a certain allocation scheme. 
 
LEMMA 1. It is the case that if a clinical trial set targets the allocation ρ then: 
 
1
1
lim   
n
i
n
i
E
n
P 


 .  
THEOREM 1. Optimal Entropy Theorem: Consider clinical trial sequence C that targets the 
allocation ρ. Then we have the following:  
a) The maximum value that the asymptotic mean entropy of any such sequence can take 
is equal to that of a clinical trial sequence where the allocation function f() is a coin 
with success probability ρ.  
b) Another clinical trial sequence with the same target allocation will achieve the same 
maximum asymptotic mean entropy if and only if: 
    i) 
2
11
1
lim  [
1
] [ ] 0
1
n
i i
n
i
n
i
E P E P
n n  
 
  
  
    
            ii) 
1
1
 lim   ( ) 0
n
i
i
n
Var P
n 
   
Note that Lemma 1 and Condition i) from Theorem 1 are not equivalent to  
             lim n
n
E P 

 . This statement is stronger than Lemma 1 and Condition i) taken 
together. 
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This theorem shows when a clinical trial sequence with a known target allocation 
achieves optimal entropy asymptotically. It connects entropy, which is a measure of the 
randomness that an interfering investigator will experience, with properties of the clinical trial 
sequence which are easier to verify. 
We now provide a simpler condition for a clinical trial allocation set to achieve optimal 
entropy. 
COROLLARY 1. Consider clinical trial sequence C that targets the allocation ρ. Then C will 
achieve the maximum asymptotic mean entropy if 
P
nP  , where the limit is in probability.  
THEOREM 2. Let { }nP  and { }nQ  be the sequences of conditional treatment assignment 
probabilities corresponding to two different trial sequences that target the allocation ρ. If  
2 2 ,  :n and    
  2(0, )n
D
n P N   , 
   20,  n
D
n NQ    ,  
 
2 2[ ]nE n P    , 
 
2 2[ ]nE n Q    , 
then we have the following two results: 
i) The asymptotic mean entropy of both trials is H(ρ) so each achieves the maximum 
entropy for that target allocation.  
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ii) There exists m ϵ N such that for all n > m, the mean entropy after n patients in the 
first trial exceeds the mean entropy after n patients in the second trial. 
 
This result shows that it is possible to rank the entropy of asymptotically optimal entropy designs 
when Pn  for each design is asymptotically normal, which is often the case.  
LEMMA 2. Let { }nP  and { }nQ  be the sequences of conditional treatment assignment 
probabilities corresponding to two different doubly adaptive biased coin designs that differ only 
in the values of the randomization parameter    Let the value of the randomization parameter be 
larger for the design corresponding to sequence{ }nQ . Then if n  : 
  2(0, )n
D
n P N   , 
   20,  n
D
n NQ    , 2 2  for some     
                                  
We will use Theorem 2 and Lemma 2 to justify an assertion about the doubly adaptive biased 
coin. 
 
3.4. Allocation Designs 
We consider designs that target a fixed allocation known before the trial, e.g. equal allocation, 
such as the fair coin, the permuted block design (Rosenberger and Lachin, 2009), Efron’s coin 
(Efron, 1971) and Wei’s coin (Wei, 1978). We also consider response adaptive designs, where 
responses are used to change the allocation proportion usually in order to assign more patients to 
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the better treatment. We will consider doubly adaptive biased coin design (Hu and Zhang, 2004), 
efficient randomized adaptive design (Hu, Zhang and He, 2009) and Ivanova’s urn design 
(Ivanova, 2003). 
  
Fair Coin. The patients are assigned to treatment by flipping a fair coin, and assigning each 
patient to treatment A if the coin comes up heads. This procedure targets equal allocation, and 
the asymptotic variance of the treatment allocation proportion is 0.25, the largest of all treatment 
allocation schemes considered. This scheme achieves optimal entropy for any trial length, 
because the probability of treatment assignment is always 0.5. 
 
Permuted Block. The patients are assigned sequentially in blocks of size m a b   by choosing 
a permutation of the a A’s and b B’s in a way where all permutations are equally likely to be 
chosen. An observer who knows the D
(n-1)
 and f() in this context can try to make predictions 
about nX . Clearly the trial sequence targets the allocation / ( )a a b  with zero asymptotic 
variance. Figure 2 shows histograms of nP  for permuted block design with 3a b  . From 
Figure 2 we see that permuted block does not achieve optimal entropy, because, j mP  , 
corresponding to the final patient allocated in each block, is Bernoulli( / ( ))a a b , which has 
positive variance. Thus, the second condition of the Optimal Entropy Theorem is violated, since 
a positive fraction 1/(a + b) of the iP  will have the same positive variance. When 3a b   the 
asymptotic mean entropy for this design is 0.49, much lower than 0.69, the maximum entropy for 
a design targeting equal allocation. It is worth noting that if a and b are large, nP  will be closer to 
a point mass at the target allocation for most of the patients that are assigned, due to properties of 
the binomial distribution. Thus increasing a b  will increase the asymptotic mean entropy for 
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this type of design. However, the maximum will never be achieved for fixed a b , and in 
practice large values of a b  are not used for this design.  
 
Efron’s Coin. The basic idea (Efron, 1971) is that as soon as the treatments become sufficiently 
imbalanced favouring one treatment, then the randomization is chosen to favour the other 
treatment in an attempt to balance more quickly while still incorporating randomization so that 
the physician can never be certain of the next treatment assignment. Choose a probability   > 
0.5. In a clinical trial with a target allocation of 0.5, the treatment allocation function is:  
    nP  = 0.5  if | ( ) |nA nAN n N  = 0,  
   nP  =  1    if  ( )nA nAN n N     0,  
   nP  =    if ( )nA nAN n N     0. 
It has been shown (Markaryan and Rosenberger, 2010) that the asymptotic variance of 
/  nAN n approaches zero . 
Efron’s coin also does not have optimal entropy because 2nP  converges the following 
attractor distribution (Markaryan and Rosenberger, 2010): 
1   with probability 
1
4
, 
1
2
 with probability 
2 1
2



, 
  with probability 
1
4
. 
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Clearly this distribution has positive variance. Since 2nP  is bounded, its convergence implies 
convergence of moments, so condition ii) of the Optimal Entropy Theorem is violated. 
The asymptotic mean entropy of Efron’s coin is: 
       2 2
1
2 1 log2 2 log 1 2 log 1
4
      

       
 
. 
For 0.84   Efron’s coin has the same asymptotic mean entropy as the permuted block design 
with block of size 3 + 3.  
 
Wei’s Coin. This clinical trial allocation scheme targets the allocation 0.5. Let the discrepancy 
 ( ) /n nA nAD N n N n    . Then 
   1Pr | , () Pr | , ( )n n n nX A f X AD f g D
        
n
D   , 
where ()g  is some non-increasing function with ( ) 1 ( )g x g x   , for example, (1 ) / 2nD  
(Wei, 1978). This design was described in Example 3 in the introduction. Efron’s coin is a 
special case of Wei’s coin. Wei (1978) showed that the expected bias in such an experiment 
approaches zero asymptotically, and that       / 2 / 1 0,1/ 1 4 (0)  
D
n nAn D n n N n N g     
when g() is differentiable at zero. Then the asymptotic variance of the allocation proportion is 
always a positive real number. Of course, this result does not apply to Efron’s coin where ()g  is 
not continuous. 
Wei’s coin achieves optimal entropy when g() is continuous on [-1, 1]. To see this note 
that Wei’s coin always targets 0.5, and that g(0.5) = 0.5 by symmetry. Then by the continuous 
mapping theorem, nP  approaches 0.5 in probability, so by Corollary 1 optimal entropy is 
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achieved. However, note that the asymptotic variance of the allocation proportion for this design 
is positive when g() is differentiable at zero, which is the case for Wei’s suggested choice of g(). 
In comparison, the asymptotic variance of the allocation proportion for the Permuted Block 
design and Efron’s coin is zero.  
 
Doubly Adaptive Biased Coin (DABC). The doubly adaptive biased coin design (Hu and 
Zhang, 2004) allocates patient j to treatment A with probability 
( 1)
ˆ( / ( 1), )n Ag N n   , where ˆ  is 
the target proportion estimated from the data. We use the choice of g(,) from Hu and Zhang 
(2004):  
 
ˆ ˆ( / )
ˆ( , ) ,
ˆ ˆ ˆ ˆ( / ) (1 ) (1 ) / (1 )
ˆ(0, ) 1,
ˆ(1, ) 0.
x
g x
x x
g
g


 

   



   


 
This g(,) is chosen because it has several desirable properties (Hu and Zhang, 2004). The 
nonnegative number  is a design parameter controlling the amount of randomization in the 
design. Let ( , )A Bp p  be the target allocation proportion as a function of pA and pB, for 
example,  ( , ) /A B B B A A B Bp p p q p q p q    for inverse Neyman allocation (Ivanova, 2003), 
where 1i iq p  , i = A, B. Hu and Zhang (2004) give the following formula for the asymptotic 
variance, 2 , of /nAN n  
 
 
2
2 21
2
2
1 1 2 1 2
2 2
2 1 2 1 1 1 2 2 2
2
1 1 2 2 1 2
2 1
, where
1 2 1 2
( , ) 1 ( , ) ,
( , ) ( , )
.
( , ) 1 ( , )
p p p p
p p p q p p p q
p p p p p p

 
 
  
 

 

 
 
 
    
    
     
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When 0  , the design is fully randomized, and the asymptotic variance is 2 21 22  ;  when 
    the design is deterministic, the asymptotic variance is 22  and is equal to the lower 
bound of the asymptotic variance of the allocation proportion. It was recommended (Hu and 
Rosenberger, 2005) to use the design with 2  . We prove the following result about DABC 
design:  
The asymptotic variance of nP  for a trial sequence using the doubly adaptive biased coin 
design with the larger randomization parameter is larger than that with the trial sequence using 
the smaller randomization parameter. 
Figure 2.3 shows histograms of nP  for response adaptive randomization designs with 
target allocation 2 / 3  . Note that the means of nP  for each figure approach the target 
allocation 2 / 3  . The DABC design achieves optimal entropy. The justification for this is 
similar to that of Wei’s coin. Hu and Zhang (2004) showed that the joint distribution of 
ˆ( / , )nAN n   is asymptotically multivariate normal when standardized by n . The Delta method 
can be used to show that nP  is also asymptotically normal. Thus it must converge to a point mass 
when not standardized. Then we can apply Corollary 1 to get the desired result. This result holds 
for all finite values of the randomization parameter . It is clear from Figure 2.3 that the variance 
of nP  is shrinking for this design as n grows. Note also the increasing normality of nP  for the 
DABC in Figure 2.3, as predicted by theory; Kolmogorov-Smirnov tests confirm this. 
It is interesting that the randomization parameter   in the DABC design, which does in 
fact affect the entropy of the trial in the finite sample case, actually has no effect on the 
asymptotic mean entropy of the trial. This follows directly from Corollary 1. The DABC design 
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achieves optimal entropy for all finite  , which means that the DABC always has greater 
asymptotic mean entropy than designs that do not achieve optimal entropy, such as permuted 
block design. Figure 2.4 illustrates this phenomenon.  
             By combining Theorem 2 with Lemma 2, that, provided the first three moments of nP  
exist for the DABC, increasing the randomization parameter does in fact decrease the entropy for 
the DABC in different sense: the mean entropy for the DABC with the smaller value of   will 
eventually exceed that of the DABC design with the larger value of   , even as both mean 
entropies approach the same limit.  
          An important question to answer is how to choose the randomization parameter   in the 
DABC design. Hu and Zhang (2004) recommended 2   because it yields a good trade-off 
between the amount of randomness the design provides and the variance of the allocation 
proportion. Our results show is that the best value of   actually depends on the length of the 
trial. This is because when the trial is long, say 200-300 patients and power is an issue, we can 
see from Figure 2.4 that we would lose very little entropy if   is increased to say, 6. However, 
this could shrink the asymptotic variance of the trial sequence by a factor of 2 or 3, which would 
add several percentage points of power. Similarly, if power is less of an issue and the trial is 
short, a smaller value of   like 1 or 2 should be chosen so that there is enough randomness; the 
trial will not be long enough for the entropy to approach its maximum. 
 
Efficient Randomized Adaptive Design (ERADE). The ERADE (Hu, Zhang and He, 2009) is 
a generalization of Efron’s coin and can target any desirable allocation. The ERADE requires 
specifying a design parameter , 0 1  . As before, ˆ  is the estimated target allocation. Then 
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the next patient is assigned to treatment A with probability ˆ  if the allocation proportion 
exceeds ˆ ; with probability   if the allocation proportion is equal to ˆ ; and with probability 
ˆ1 (1 )    if the allocation proportion exceeds the estimated target allocation. Hu, Zhang and 
He (2009) recommended using  in [0.4, 0.7]. This design achieves the lower bound of the 
asymptotic variance of the allocation proportion (Hu, Rosenberger and Zhang 2006). Efron’s 
coin can be thought of as a special case of ERADE where 1/ 2   is known in advance. 
ERADE does not achieve optimal entropy. To see this, note first that ERADE targets the 
allocation ρ, with three different coins that are each a fixed function of the estimated target 
allocation, so that nP  will converge to a discrete distribution with at most three point masses. 
Upon further inspection we see that the discrete attractor distribution will only have two point 
masses. This is because the mass placed on the second point mass, ρ, will approach zero. The 
reason for this is that the allocation proportion has an asymptotic normal distribution when 
properly standardized (Hu, Zhang and He, 2009), which means that probability that it is exactly 
equal to ρ must approach zero because the normal distribution has a continuous density. But nP  
is only equal to the second point mass when the estimated target allocation is exactly equal to ρ. 
This is why the attractor distribution for nP  only has two point masses. Since its mean must 
approach ρ, and one point mass is larger than ρ and another is smaller, the discrete attractor 
distribution must have positive variance so Condition ii) of the Optimal Entropy Theorem is 
violated. Because the two point masses are relatively far apart, ERADE tends to have the lowest 
mean entropy of the response adaptive design we considered.  
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Ivanova’s urn. The design from Ivanova (2003) is implemented by an urn with three different 
kinds of balls: immigration, treatment A, and treatment B. Balls are drawn from the urn 
sequentially. If the ball drawn is immigration, one ball is added to the urn for each treatment and 
no patient is assigned. If the ball drawn is one of the treatment balls, the next patient is assigned 
that treatment and the ball is replaced. If the patient fails, one ball from that treatment is removed 
from the urn. If the patient does not fail, the urn composition remains unchanged. This design 
achieves lower bound of the treatment allocation proportion variance (Hu and Rosenberger, 
2003) but only targets one allocation. 
Ivanova’s urn design also does not achieve optimal entropy. To see this, note that the 
mean number of balls of type A or B will approach 0 / (1 )AZ p  or 0 / (1 )BZ p  respectively 
(Ivanova, 2003), where 0Z  is the initial number of immigration balls. Since the lower bound for 
the number of balls of any type is zero, this means that the number of balls in the urn must 
eventually be less than some upper bound U with some minimum probability. This means that 
the urn proportion of type A balls must have positive variance, since there is a lower bound on 
the transition probabilities between different consecutive values of this allocation proportion 
when the urn is bounded by U. Since the probability of assigning the next patient to A is clearly 
not constant as a function of  the number of type A balls there must be a lower bound on the 
average variance of nP , so Condition ii) of the Optimal Entropy Theorem is violated. Note that in 
Figure 2.3, the mean approaches ρ = 2/3, but the variance does not approach zero. The variance 
is still rather small, however, so the urn has a reasonable amount of entropy. 
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3.5. Conclusions 
In this work, for an allocation design, we have defined the random variable nP  and shown how 
the distribution of this random variable is connected to the asymptotic mean entropy of the 
sequence of assignments for that design. We proved the Optimal Entropy Theorem, which states 
that a coin with success probability equal to the target allocation always achieves the maximum 
amount of entropy, and gives necessary and sufficient conditions for a clinical trial sequence that 
targets that allocation to achieve this maximum. Then we applied this theorem to existing 
designs to show which clinical trial designs achieve this optimum amount of entropy. We have 
shown that when nP  is asymptotically normal there is a direct connection between its variance 
and asymptotic mean entropy, and have demonstrated more generally that entropy often 
decreases with the variance of  nP . Theorem 2 and Lemma 2 together offer, for the first time, a 
clear explanation of why increasing the randomization parameter in the doubly adaptive biased 
coin design decreases the randomization of the design. Theorem 1 further shows that the choice 
of this randomization parameter has no effect on the asymptotic mean entropy. 
           Some implications of our findings are counterintuitive. The first is that, if a trial set targets 
the allocation 0.5 and achieves optimal entropy, then, as the trial becomes longer, the second half 
of the trial will eventually contribute at least as much to the mean entropy than the first half. To 
see why, note that if the trial achieves optimal entropy for  0.5   then after a certain n the 
average of all   iP  must have means arbitrarily close to 0.5 and variances arbitrarily close to zero. 
Since 0.5 is the point with maximum entropy, the entropy from the second part of the trial must 
be at least as great as from the first part. This means that even as the investigators gathers more 
data about the history of the trial, their ability to predict the next treatment assignment will, in 
fact, decrease on average. This is a direct consequence of both conditions of the Optimal Entropy 
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Theorem. In fact, for any target allocation, the second half of an optimal entropy trial may 
eventually contribute more to the mean entropy than the first half but this is only certain for 
 0.5  . The reason this does not necessarily hold for trial sequences with arbitrary ρ is that the 
mean of  nP  may move from 0.5 to ρ more slowly than the variance shrinks. 
            An interesting issue that warrants further investigation is the relationship between the 
variance of  nP  and the asymptotic variance of /nAN n . It is clear that the allocation scheme from 
Example 2 in Section 2 has the minimum possible asymptotic variance of /nAN n , yet  nP   
always has the maximum possible variance. Now consider a trial designed as follows: a fair coin 
is flipped. If it is heads, then the treatments are assigned: AAABAAAB… If the coin lands tails, 
the treatments are assigned: BBBABBBA… Random variable  nP  still has the maximum possible 
variance, yet the asymptotic variance of the allocation proportion is now infinite. This shows that 
if the variance of  nP  is large, there is very little that can be said about the asymptotic variance of 
the allocation proportion. However, if the variance of   nP  is very small, or even approaches zero, 
as in the case of optimal entropy, it is not known if greater restrictions can be placed on the 
asymptotic variance of the allocation proportion. If a lower bound for the asymptotic variance of 
an optimal entropy trial could be established, this would be an important step in understanding 
what an optimal sequential clinical trial should look like. It is not known if there is an optimal 
entropy design that achieves the lower bound of the asymptotic variance for asymptotically 
normal allocation proportions when the target allocation is not known in advance (ERADE 
achieves this lower bound, but it is not optimal entropy). Using functions that have unbounded 
slope in an neighbourhood containing zero, we have found an optimal entropy design based on 
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Wei’s Coin that targets equal allocation and appears to have zero asymptotic variance, but this 
fact remains to be proved. 
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Figure 3.1. Density of nP  for designs. Consider the examples given in Section 2 with the total 
sample size n = 20 and 80. 
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Figure 3.2. Density of nP  for designs in Section 4 with fixed target allocation. Permuted block 
design with blocks of size 6 (3+3), Efron’s coin with 0.75   and Wei’s coin with ( ) 1g x x  . 
For each design, three different values of total sample size n are considered. 
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Figure 3.3. Density of nP  for response adaptive designs from Section 4. For all designs, pA = 
0.50, 0.75Bp   and 2 / 3  . The DABC uses 8  ; the ERADE uses 0.5  ;  Ivanova’s urn 
design uses an initial urn composition of 10 of each type of ball. 
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Figure 3.4. Asymptotic mean entropy. Consider permuted block design of size 6 (3+3) (solid 
line at 0.49) and the Doubly Adaptive Biased Coin design with 0.44 Ap  , 0.56Bp  ,  =2 (top 
dashed line),  =10 (middle dashed line), and  =100 (bottom dashed line). Both designs target 
1/ 2.   The figure illustrates that the DABC achieves optimal entropy for all values of  , and 
that larger values of gamma yield less entropy for smaller n. The permuted block does not 
achieve optimal entropy.  
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CHAPTER 4: THE BROWNIAN DISTANCE COVARIANCE IN SURVIVAL ANALYSIS 
 
4.1 Introduction. 
 
The problem of relationship detection is one of the oldest questions in statistics, dating back 
to the nineteenth century, before the existence of modern statistical theory. The most lasting 
contribution from this time period is linear regression, a method that is still in use today. Its 
optimality was first justified using the Gauss Markov Theorem, and later UMVU estimation. In 
addition to being optimal for detecting a straight line relationship, simple linear regression also 
has the power to detect other monotone relationships, and even some relationships that are not 
monotonic. The technique can be augmented by adding higher order terms.  
However, there is still a need within the discipline to develop relationship detection 
techniques for situations when very little about the form of the relationship is known. In 2009, 
Szekely and Rizzo proposed the Brownian Distance Covariance, which uses a simple statistic to 
detect whether two random variables are independent. This method is based on the relationship 
between the difference of the joint and product marginal characteristic functions and a 
trigonometric weight function. This technique can detect dependencies that are more complex 
than simple functional relationships with noise added. It can also be used to detect relationships 
between sets of vectors. In 2011, Reshef and others proposed the MINE statistic, which uses a 
series of grids to select a relationship based on mutual information. This technique is based on 
ranks and has lower power for moderate sample sizes. The authors also claim that this technique 
has a very similar power for different relationships with the same amount of noise. 
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Survival analysis has long employed the Cox model to test for differences among covariates. 
This model allows for the testing of whether covariates are associated with time to event. One of 
the strengths of this model is that the baseline hazard function need not be specified. However, 
this model relies on the proportional hazards assumption, which may not always hold. For 
example, one way this assumption may be violated is if the two survival curves cross for certain 
values of the covariate. However, even in this case meaningful differences in survival time may 
exist. The Aalen additive risk model (McKeague and Sasieni, 1994) is an alternative that avoids 
this problem but is more limited in the number of covariates that it can handle. Thus the 
discipline might benefit from new approaches to detecting survival time differences. Here we 
propose using the Brownian Distance Covariance to search for relationships in survival data that 
may not be detectable using the Cox model. This requires modifying the Brownian Distance 
Covariance so that it can accommodate right-censored data. There are two modifications we 
propose to the Brownian Distance Covariance to accommodate the right censoring. The first is to 
use the fact that, if the covariate and censoring time are independent, then the conditional 
distribution of the failure time given the covariates and the censoring time is unit exponential. 
The second approach involves imputing the censored failure times by sampling from the known 
failure times when each failure time is weighted by the standard cumulative hazard function. We 
proceed to compare each of these two approaches to the Cox Model, which is designed to detect 
monotone relationships. We also compare these existing approaches to the method used by Kwak 
in her 2006 thesis. Kwak’s method is based on the convergence of cumulative hazard functions 
to a Brownian Bridge. We also compare the first two approaches to linear regression as well, as 
they are based on complete data. 
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4.2  Methods. 
We will now describe Brownian Distance Covariance in detail (Szekely and Rizzo, 2009). Let  
fX, fY , fX,Y denote the marginal and joint characteristic functions of two continuous random 
vectors in    and   . Let V(X,Y,w) = 2
,
R
| ( , ) ( ) ( ) | ( , , , )
p q X Y X Y
f t s f t f s w t s p q dtds

 , where w is 
a positive weight function. 
For certain reasons we want a non-integrable trigonometric weight function. This leads to 
distance correlation:  
      
      
              
. 
Now let 
    akl=|Xk-Xl|p bkl=|Yk-Yl|q ,  
    Akl=akl-ak.-a.l+a..  and Bkl= bkl-bk.-b.l+b..  and the “.” indicates a marginal mean. 
   Then V
2
n(X,Y)= 
V
2
n and R
2
n tend almost surely to their theoretical values, R
2
 and V
2
. Both are invariant under 
affine transformation of their arguments. There are two special values: 
R
2
 =0 if and only if X an Y are independent, 
R
2
=1 implies strict linear dependence, 
nV
2
n has two different limit distributions in the case of dependence and independence. 
We now discuss the first imputation method for the Brownian Distance Covariance in 
more detail. The idea is to test for independence of the failure times and a set of covariates by 
first assuming that the covariates are independent of them. As usual, the censoring time is 
assumed independent of the failure time.  Further assume that this independence holds for the 
covariates. Also, let    denote the minimum of the failure time and the censoring time. Also let 
   denote an indicator equal to 1 when    is the failure time. The first part of this idea is that the 
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cumulative hazard as a function of the failure time is exponential given the covariates. That is, 
we generate 
  
      
                         
     . 
Here    is the observed failure time,    is the censoring time   
  is the cumulative hazard 
and   is a unit exponential random variable. This can be generated with several thousand 
replications to create a distribution of Brownian Distance Covariance values using replications 
from the data when they are compared to the covariate vectors. Then the observed value of the 
Brownian Distance Covariance can be compared to the significance level from this distribution. 
The reason that this bootstrapping is necessary is that the null distribution of the Brownian 
Distance Covariance is unknown and depends on the underlying distribution, so that the null 
distribution must be generated experimentally. One issue that arises from this technique is 
whether the power would be increased with the number of covariates that are not independent of 
the failure time, if each covariate that was not independent carried the same strength of  
relationship. This is a general question related to the structure of the Brownian Distance 
Covariance that can be addressed experimentally to a certain extent.   
The second approach to imputation with the Brownian Distance Covariance involves, for 
each censored observation, sampling from the remaining failure times that are greater than the 
observation when the sampling of each failure time is weighted by the difference in the standard 
nonparametric survival curve estimate at that failure time. 
Kwak’s method, (Kwak, 2006) involves comparing the standardized supremum of the 
difference of a standard cumulative hazard Nelson-Aalen estimator with that of a cumulative 
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hazard analogue derived from an empirical process that incorporates covariate information in a 
Vapnik-Chervonenkis class of sets in the covariate space. The test statistic is: 
  
                             
       , 
Where 
      is the usual Nelson Aalen estimator for the cumulative hazard function and                   
                                                    
      = 
             
           
 
 
,  
where    represents an empirical process, M represents the event and Z represents the covariate. 
The test statistic converges to the linear functional of three Brownian Bridges, one of which is 
independent of the other two.   
 To implement the simulations, the covariates were generated first, and then the survival 
times and censoring times were generated independently conditional on the covariate vector. The 
covariate vector was generated from a Weibull(1,10). Let cv denote the covariate vector. The 
failure time vector was chosen from one of the following five: 
 6+0.5*cv +    where                  
Uniform(min(cv), max(cv))+     
.     +   
sin(                 )   
2(             /             
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The noise level was set to three and there were two censoring levels indicated. The first, 50%, 
was generated by re simulating the failure times and taking the minimum. The second, 20%, was 
generated separately for each type of failure time by generating a censoring time with a constant 
added to the formula for generating the failure time so that the target censoring rate was 
achieved.   
 
4.3. Results. 
Consult Tables 1-6 for the power calculations comparing the different methods. For the second 
imputation method, the Brownian Distance Covariance tends to outperform the Cox model and 
linear regression for the parabolic and sinusoidal relationships, while the Cox model performs 
better for the monotone relationships. The Cox model tends to be more powerful than Kwak’s 
Method except when the relationship is sinusoidal. Kwak’s method appears to be less powerful 
than Brownian Distance Covariance Imputation, and linear regression under the first imputation 
method appears to be more powerful than the Brownian Distance Covariance.  
  
4.4 Conclusions. 
The Brownian Distance Covariance appears to be a superior method to the Cox model for 
detecting nonlinear relationships. The superiority of the Brownian Distance Covariance to linear 
regression depends on the imputation method used. Whether the Brownian Distance Covariance 
is superior to the Cox Model at detecting a single related covariate when there are multiple 
covariates being tested simultaneously is an important question that remains to be answered. 
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Table 4.1. Power calculations for both imputation methods and heavy censoring. 
Relationship Cox model Kwak’s BDC #1 Linear Reg #1 BDC #2 Linear Reg #2 
Noise 0.05 0.06 0.05 0.95 0.06 0.04 
Linear 0.98 0.30 0.52 0.88 0.93 0.94 
Exponential 0.81 0.20 0.75 0.97 0.35 0.31 
Parabolic 0.75 0.45 0.89 0.35 0.93 0.45 
Sinusoidal 0.09 0.19 0.61 0.08 0.85 0.18 
 
Table 4.2. Power calculations for both imputation methods and light censoring. 
Relationship Cox model Kwak’s BDC #1 Linear Reg #1 BDC #2 Linear Reg #2 
Noise 0.05 0.06 0.05 0.97 0.06 0.04 
Linear 1 0.39 0.59 0.92 0.96 0.94 
Exponential 0.88 0.32 0.86 0.97 0.46 0.39 
Parabolic 0.79 0.55 0.95 0.39 0.96 0.62 
Sinusoidal 0.12 0.29 0.77 0.08 0.97 0.28 
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APPENDIX 1.1 TRANSITION PROBABILITIES FOR THE MARKOV PROCESS 
Though we have two processes corresponding to the two treatment arms, it is sufficient to 
describe the behavior of a Markov process corresponding to a single treatment arm with success 
rate of p, 1q p  . In similar derivations in Ivanova et al. (2001) and Ivanova (2003) the state 
that the process is in was a function of the number of balls currently in the urn. In the second 
order urn, the state that the process is in is determined by the response of the previous patient and 
the number of balls currently in the urn. The initial urn contains one ball of each type. Assume 
that one patient has been already treated and response observed. If the response was a success, X1 
= 1, the Markov process starts at the state (1,1), if response was a failure, X1 = 0, the Markov 
process starts at the state (0,1). Assume that the process is at the state (0, )m , 0m  , at time t. 
The following transitions are possible in time t : 
(0, ) (0, 1) with rate 
(0, ) (0, ) with rate 
(0, ) (0, 1) with rate 
m m mp t
m m mq t
m m a t
  
 
  
  
Similarly, if the process is in the state (1, )m , 0m  , at time t, the transitions in time t  are: 
(1, ) (1, 1) with rate 
(1, ) (1, ) with rate 
(1, ) (1, 1) with rate 
m m mq t
m m mp t
m m a t
  
 
  
 
Let 0, ( )mp t  equal the probability of being at state (0, )m  at time t, and 1, ( )mp t  equal the 
probability of being at state (1, )m  at time t. To obtain backward equations we consider all 
possible ways to get to states (0,m) and (1,m) by time t: 
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(1, 1) (0, ) with rate ( 1) ,
(0, 1) (0, ) with rate ,
(0, ) (0, ) with rate 1 ,
(0, 1) (1, ) with rate ( 1) ,
(1, 1) (1, ) with rate ,
(1, ) (1, ) with rate 1 . 
m m m q t
m m a t
m m mq t m t a t
m m m p t
m m a t
m m mp t m t a t
   
  
      
   
  
      
  (2) 
Define generating functions 
0 0, 1 1,
0 0
( , ) ( ) , ( , ) ( )m mm m
m m
G t z p t z G t z p t z
 
 
   .  (3) 
The system of partial differential equations (1) and its initial and boundary conditions are 
obtained from (2) and (3). 
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APPENDIX 1.2 TELESCOPING PROPERTY OF THE URN 
Define  
1
, 1 1 2
0
( ) ( ( ) ( ) 1 2 )
m
j m
k
a z j m z j z j k


 
     
 
 , m ≥ 0. We would like to show that 
, ,
1
j k j m
k m
a a

 
 .  We first show that, , 1 ,/ 0.5j m j ma a  . This ratio is 
   
     
 
1
, 1 1 1
1
,
1 2 1 2
0 0
1
1 1
1 2 1 2 1 2
0 0
1
1
( ) 1 ( )
( ) ( ) 1 2 ( ) ( ) 1 2
( ) 1 ( )
( ) ( ) 1 2( 1) ( ) ( ) 1 2 ( ) ( ) 1 2
( ) 1
( )
j m
m m
j m
k k
m m
k k
a z j m z j m
a
z j z j k z j z j k
z j m z j m
z j z j m z j z j k z j z j k
z j m
z j m z



 

 
 
    
  
      
  
 
    
  
          
  
 


 
 
 1 2( ) ( ) 2 3j z j m  
 
         
1 2 1 1 2
1 1 1 1 1
( ( ) ( ) 2 3) ( ( ) )( ( ) ( ) 2 3) 4 4 2z j z j m z j m z j z j m
    
      
, 
 
because all terms are nonnegative and 1( ) 1z j m  .   
The geometric sequence 0.5n  has the property that the sum of all terms beyond the mth
 
term is equal to the mth
 
term.  Then, ,j m ka   < ,( )(0.5)
k
j ma  and therefore , ,
1
j k j m
k m
a a

 
 . 
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APPENDIX 2: PROOFS OF LEMMAS 1 AND 2 AND THEOREMS 1 AND 2. 
Proof of Lemma 1. Clearly when a trial sequence targets  , [ / ]nAE N n   because /nAN n  has 
compact support. Note  
   
1 1
1 1
 .
n n
nA nA
i i
i i
N N
I X A E Pr X A
n n n n 
 
     
 
   
Also since 
      
( 1) ( 1)
1 1
(Pr | , () )Pr( )
nP n
f p I X A f p
 
 

  
n n
n n
T S
D  T . 
We have  
 
   
       
   
       
   
       
 
1 1
1 1
1 1
1
1 1
0
1
1 1
0
1 1
E Pr | , Pr
Pr Pr | ,
Pr | , Pr
Pr .
n n
n
n
n
P p I X A f p dp
pI X A f p dp
X A f
X A
 
 
 
 

 

 

   
 
         
 
 

 

n n
n n
n n
n n
T S
n n
T S
n n
T S
D  T
T D  
D  T
 
And from this the desired result that  
1
1
lim
n
i
n
i
E P
n



  follows. 
Proof of Lemma 2. 
Rewrite the treatment allocation function for the doubly adaptive biased coin as: 
                                                  
ˆ
ˆ( , )
ˆ1/ 1
ˆ ˆ(1 )
1/ 1
g x
x
 



 

 
   
 
. 
Choose ˆ ˆ( , )h x x    . We see from p. 273 (Hu and Zhang, 2004) that : 
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                                      ˆ( ( ), ( )) (0, )
D
n x n N      , 
where 
                                   
2 2 22
3 31
2
23
3
2
1 2 (1 )(1 2 ) 1
1
  
   



 
 
     
 
 
 
 
and 
                                         
2
1
2 2 21 1 2 2
3
1 2
,
,
(1 ),
(1 ) (1 )
( ) ( ) ,
1
| ,
= | .
ˆ
p p p p
p p
g
x
g

 

 
  
 

 



 
   
 
  





 
Thus the asymptotic normality of     and n nn P n Q    follow immediately from the 
Delta method. 
We also see from the presentation of the Delta method on p. 61 of Lehmann and Casella 
that: 
                             ˆ ˆ( [ ( , ) ( , )], [ ( , ) ( , )])n g x g n h x h         
tends in law to (0, )N  , where: 
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ˆ
 and 
ˆ
T
g g
x
B B B
h h
x
 
 


  
 
     
  
 
  
. 
This is because the matrix B is nonsingular, due to the choice of h() (see computations of B 
below). We know from the Cramer-Wold device that the marginal distributions of 
                                           ˆ ˆ( [ ( , ) ( , )], [ ( , ) ( , )])n g x g n h x h         
tend to the marginal distributions of (0, )N  . 
Thus, part i) of Claim 3 follows from part i) of Claim 2. Now we show part ii). It is 
known that the variances of the variables in the bivariate normal density are just the diagonal 
elements of  . Thus we see from matrix multiplication that the asymptotic variance of 
ˆ[ ( , ) ( , )]  (i.e. the first element of ) n g x g     does not depend on the bottom half of B. To 
compute this element explicitly, we first note that because we are evaluating the Jacobian matrix 
at ˆx    , the first row of B is equal to ( , )
T  . Then we use maple, specifically the 
“multiply” command for matrices and the “simplify” command for the resulting algebraic 
expression to obtain: 
2 22 2
31
1 2 1 2
  
 

 
. To verify that this quantity is strictly monotone increasing 
in   we compute  and 
ˆ
g g
x
 

 
 
 explicitly using calculus.  
1
2 2
2
2
1 1 1 1ˆ ˆ(1 )( 1) ( ) ˆ ˆ(1 ) (1/ 1)( )
ˆ 1/ 1 1 1
ˆ ˆ( (1 ) )ˆ1/ 1
ˆ ˆ( (1 ) )
1/ 1
T xg x x x
x T
x




     

 
 

 
           
   
   
 
, 
80 
where 
ˆ1/ 1
1/ 1
T
x

  
  
 
. Similarly, 
                      
2
2
ˆ ˆ ˆ1/ 1 1/ 1 1/ 1
ˆ ˆ ˆ( (1 ) ) (1 )
(1 )ˆ1/ 1 1/ 1 1/ 1
ˆ ˆ ˆ( (1 ) )ˆ1/ 1
ˆ ˆ( (1 ) )
1/ 1
g Tx x x
T
x
  


   
  

  
 
       
                  
   
   
 
, 
 ˆx     and hence 1,T  so we have  and 1       . Then the first element of   
becomes 
2 22 2
31
(1 )
1 2 1 2
  
 


 
. We need to show that this is monotonically increasing in γ. Note 
that it is a positive linear combination of two other functions, 
2
1 2


 and 
2(1 )
.
1 2




 If we can 
show that each of these functions is monotonically increasing in   then it will follow that the 
first element of   is as well. This in turn is equivalent to showing that the logarithm of each 
function is monotonically increasing in  . When 0   
                                 
2
log( ) 2log( ) log(1 2 )
1 2

 

  

, 
2
2 2
[2log( ) log(1 2 )] 0,
1 2
(1 )
log( ) 2log(1 ) log(1 2 ),
1 2
2 2
[2log(1 ) log(1 2 )] 0.  
1 1 2
d
d
d
d
 
  

 

 
  
    


   

     
 
 
Thus we have shown that a larger value of  results in a larger asymptotic variance of 
( )nn P  .QED  
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Proof of Theorem 1. 
a) Consider function  ( )  ( )  (1 ) (1 ) . H x xlog x x log x    H(x) is strictly concave in (0,1) since 
its second derivative is strictly negative. Using Jensen’s inequality (Casella and Berger, p. 
190) we get ( [ ])  [ ( )]H E x E H x  and that equality holds only when concavity is not strict, or 
when ( [ ]) 1P X E X  . Since concavity is strict, we must have that the density is a point 
mass with probability 1. There is a special consideration for a density that assigns mass to the 
points 0 or 1, which are not in (0,1). However, because (0)  0 (1)H H  , we know that such a 
density could never maximize the entropy, since ( )  0H x   for all  0,1 x . Thus we see that 
the maximum asymptotic mean entropy can be achieved by a collection of distributions Pn 
that are all point masses, i.e. coins each with nnP c , a constant. We call such an allocation 
procedure “coin-based.” Now we show which sequence of point masses achieves it. 
Define the mean entropy as :  
 
1 1
1 1
( ) [ log  (1 )log(1 )]
n n
j j j j j
j j
H c c cc c
n n 
      . 
Say we want to maximize 
1
1
( )
n
j
j
H c
n 
  or, equivalently, minimize 
1
1
( )
n
j
j
H c
n 
  given the 
constraint 
1
1
 
n
j
j
c c
n 
 .  
Using Lagrange multipliers we search for critical points: 
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 
1 1
[ log  (1 )log(1 )]j j j j j
j j
d d
c c c c
dc n d n
c
p
   
 
 
 
, 
for each .jc  This leads to: 
 
1 1
[log log(1 )]j jc c
n n
   ,  
or log( 1( ))j jc c   ) for each jc . Since log() and / (1  )j jc c  are both one to one functions in 
(0,1) and λ is a constant, we must have that 
jc  is a constant for all j. Since the jc  have mean c, 
that constant must be c. Thus, for any allocation procedure with n coins, equal probabilities for 
each coin are required at the critical point for expected negative entropy. This must be a 
minimum, because the boundary points have the highest negative entropy, so the minimum 
cannot be there. Thus entropy is maximized there. 
However, we are not done because the mean of the probabilities is usually not exactly c, 
even if it asymptotically targets c, and can be different for the same n and different allocation 
procedures that asymptotically target c. 
But this can be easy resolved. Note that the maximum mean entropy for a coin based 
allocation procedure with mean of coins of mc  and n patients is just ( )mH c . Since the conditions 
require: lim m
n
pp

  and H(x) is continuous, it follows that maximum expected  mean entropy for 
any such allocation procedure approaches H(p), which is the asymptotic mean entropy for a 
biased coin with probability p. This proves a)  QED 
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Proof of b) i).  
Assume otherwise. By Lemma 1 it must approach ρ.  
Lemma 3.  Then there must exist an ε,    > 0 such that: 
 lim ( | ( )i
n
P mean P

  ρ |> ε |,  i n ) >    . 
Proof of Lemma 3.  Assume there is no such ε. Then the probability that one of the first  n  
distributions 
jP  is within some small γ of ρ will be approach 1 as n approaches   for any 
positive γ. The terms in the sequence where this does not hold will each contribute a maximum 
value of 1 to the variance of the first n means. Thus the variance will approach γ2 from above for 
any γ, so it will approach zero, which we assumed was not true.  QED  
 
For any such trial, the entropy is bounded above by a trial that consists of a sequence of 
coins where the success probability of the i
th
 coin is equal to the mean of    iP .  
Consider the subset of the treatment assignments that satisfy the conditions of Lemma 3 
for some ε,   > 0 in this coin trial. Call it S.  Because the means of all   iP  in S are bounded away 
from ρ, we must have three possible scenarios: 
i) There are subsequences S1 and S2 of S, each with positive density in S, such that all 
elements of S1 are greater than ρ + ε and all elements of S2 are less than ρ - ε. 
ii) There is a subsequence S1 of S with positive density in S, such that all elements of S1 are 
greater than ρ + ε and a subsequence S2 with positive density in the original sequence 
such that S2 > ρ. 
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iii) There is a subsequence S1 of S with positive density in S, such that all elements of S1 are 
less than     and a subsequence S2 with positive density in the original sequence such 
that S2 > ρ. 
The reason we must have one of these three possible scenarios is that the asymptotic mean of the 
coins is ρ, so we must have a sequence of positive density on the opposite side of ρ if there is a 
subsequence with positive density       or      .  
Given each of these three cases, here is how we create a sequence with the same 
asymptotic mean and asymptotically better entropy: 
(2) Replace each of S1i S2i , the i
th
 elements of S1 and S2 , with 1 2( ) / 2i iS S  
It follows that the new sequence has higher entropy, because H () is concave, implies   
1 2
1 2
1 1
( ) ( ),and
2 2 2
i i
i i
S S
H H S H S
 
  
 
 
1 2
1 22 ( ) ( )
2
i i
i i
S S
H H S H S
 
  
 
. 
However, this does not prove that the asymptotic mean entropy is greater. 
 
Lemma 4. The difference  1 22
2
i iS SH
 
 
 
  1 2( )i iH S H S  is bounded away from zero. 
First part: Fix 1 2( ) / 2i iS S   . Then let 1  iS k   and 2  iS k  . Start with   0.k   Without 
loss of generality, let 2   iS be closer to 0.5. As k  increases,  1  iH S  will decrease more than 
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2( )iH S  increases, because the second derivative of H is negative. Meanwhile, 
1 22
2
i iS SH
 
 
 
 is 
constant. Thus, the difference  
1 22
2
i iS SH
 
 
 
    1 2i iH S H S  
is increasing as a function of k . Since  k  > / 2 ,    1 2 1 2) / 22 ( ( )i i i iH S S H S H S    is 
bounded from below by: 
   2Q H    
1 1
2 2
H H   
   
     
   
. 
Second part: ( )Q u  is decreasing as a function of   < 1/2, and increasing as a function of   > 
1/2. 
To prove the second part, we know that 
( )
log( / (1 ))
dH
d

 

   . Let k = / 2  It then follows 
that: 
( )
2log( / (1 ))
dQ
d

 

   + log log( )
1 1
k k
k k
 
 
  
 
    
, 
which becomes: 
            [2log log log ] [2log 1 log 1 log 1 ]k k k k                   
If   = 1/ 2   this derivative is clearly zero. Now note that      2log logR v v v k     
 log v k  is decreasing in v  for 0v   since  '
2 1 1
0 R v
v v k v k
   
 
by convexity of  1 / v . 
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Thus for 0.5   the   0Q    and for 0.5     0Q   . Thus Q is minimized for the value of 
   closest to 0.5, so it is always bounded away from zero for any fixed  . Now note that 
 / 2 k  . Also, 
1 1
  (1 )
2 2
     , so H( ) is bounded away from zero. The difference  
       1 2 1 22 2 0.5 .
2 2 2
i i
i i
S S
H H S H S min H H H Q

 
  
      
             
      
 
Thus Lemma 4 is proved.  
 
Because the increases in entropy caused by the transformation (2) for each i are bounded away 
from zero over a set of positive density, this transformation increases the asymptotic mean 
entropy without changing the asymptotic mean, so the original sequence cannot have optimal 
entropy. Thus   cannot exist, so our original assumption must be wrong. QED 
 
Proof of b) ii). 
We proceed by contradiction. Assume that 
1
1
lim   ( )
n
k
n
k
Var P
n 
  > 0. 
This is our original assumption.    
Lemma 5: Then there exists 0    such that  
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  
 
1
1
lim    0
n
k
n
k
I Var P
n



   
where ()I  is an indicator function. In other words, the set of   kP  with variance larger than  has 
positive density in the infinite trial. 
Proof of Lemma 5. Assume otherwise. Then we show that 
1
1
lim   ( )  
n
k
n
k
Var P
n



  for any  0  , 
which contradicts the original assumption. 
Let  / 2  .  Then we write   
     
   
1 1 1
1 1
1 1 1
  ( )  ( )
1 1
    ( ).
4
n n n
k k k k k
k k k
n n
k k k
k k
Var P I Var P Var P I Var P Var P
n n n
I Var P I Var P Var P
n n
 
 
  
 
         
         
  
 
    
Because the maximum variance for a kP  is 1/4  
   
 
1 1
1
1 1 1
   
4 2
1 1
 .
4 2
n n
k k
k k
n
k
k
I Var P I Var P
n n
I Var P
n

 


 

         
    
 

   
Because of our hypothesis, the above quantity approaches δ/2 in the limit. This is less than ,   so 
our claim is proved.  
With this lemma proved, we now return to the main result. We now show that the 
asymptotic entropy must be less than in the optimal design. To do this we first prove Lemma 6. 
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Lemma 6: Take   as in Lemma 5 and each iP  with variance >  in Lemma 5 have mean  i . 
Now we construct a new sequence of random variables Yi such that Yi = i i( ) / 2X  . We claim: 
3
[ ( )]  [ ( )]  
4
i iE H Y E H X   . 
Proof of Lemma 6.  
[ ( )]  [ ( )] [(1 ) (1 )]i i i i iE H X E X log X E X log X    . Similarly for iY  . Now we show  
(1)        
3
[(1 )log(1 )] [(1 )log(1 )]
8
i i i iE X X E Y Y        
Using the fact that iX  is restricted to [0, 1], we can apply the Taylor series for log(1 iX ) to 
obtain 
 
2 3 2 3 4
(1 ) (1 )  (1 )      ...
2 3 2 2 3 3 4
i i i i i
i i i i i
X X X X X
X log X X X X
 
       

 

 
 
   
  
 
Note that ( ) / 2 ( ) / 2 i i i i i iY X X       . Thus Yi and Xi  have the same mean, but Yi is 
always closer to that mean than Xi. Thus Yi is also restricted to [0, 1], and we can obtain the 
Taylor series: 
2 3 4
(1 ) (1 )  ...
2 2 3 3 4
i i i
i i i
Y Y Y
Y log Y Y
 
       
  
  
Now let vi = Var( iX ). Then Var( iY ) = vi/4. Now note: 
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3 42[ ]
[(1 ) (1 )] [ ]  ...
2 2 3 3 4
i ii
i i i
E X E XE X
E X log X E X
               
  
 
by linearity of expectation. Similarly for Yi . Take k > 2 and “k choose j” be denoted as 
k
j C  .  
Now note: 
i i
0 0
0 0 0
X μ 1 1
 [( ) ]   
2 2 2
1 1 1
 ( [ ])    .
2 2 2
k k
k k k j k j k j k j
i j i i j i ik k
j j
k k k
k j k j k j k j k k
j i i j i i j ik k k
j j j
E Y E E C X C E X
C E X E X CE X E X CE X
  
 
 
  
   
            
   
     
                          
     
 
  
 
Here the last inequality follows from  Jensen’s  inequality and the convexity of   kiX on the unit 
interval when ( 1)j  . Because  ,   [ ]j k j k j k ji i i i iCov X X E X E X E X          is clearly greater than 
0 on [0, 1] 
0
 2 .
2 2
k kk
i ik k k k
i j ik k
j
E X E X
E Y C E X

                  
 
   
It then follows that  
k k
i iE Y E X       ,  k > 2, and therefore that:   
3[ ]
2 3
iE X 

 
4[ ]
3 4
iE X 

…  >  
3[ ]
2 3
iE Y 

 
4[ ]
3 4
iE Y 

… 
Because [ ]  [ ]i iE X E Y  and      3 / 4  3 / 4 i i iVar X Var Y v     we have  
    2 2    i i i iVar X Var Y E X E Y           2[(
2[ ]
[ ])
2
i
i
E X
E X   (
2[ ]
[ ])]
2
i
i
E Y
E Y   
2[ ]
[ ]
2
i
i
E X
E X   
2[ ]
[ ]  
2
i
i
E Y
E Y   
3
8
 . 
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This proves (1). 
Note that by symmetry,    
3
[ log( )]  [ log( )]  
8
i i i iE X X E Y Y   , 
because (1) is true for all possible iP  and we can just take 
'
  1i iX X   where 
'
iX  is clearly also 
some iP .  Then we add (2) to (1) and take the negative of both sides of the equals sign, because 
both of these expectations are negative in the entropy formula. Thus we have:  
3
[ ( )]  [ ( )] ε
4
i iE H Y E H X  .  
Lemma 7: The sequence of expected entropies for the sequence of iP  with Var( iP ) >   in 
Lemma 5 are  
i) bounded away from  
ii) bounded above by  
the maximum expected entropy attained by a point mass at p, except possibly on a subsequence 
without positive density.  
Proof: Assume i) is false. Then for all  0    there exists a subsequence with positive density 
such that the entropies of all elements in the subsequence are within   of that entropy attained 
by a point mass at p, denoted by ( ).H p  Choose ε / 2  . Now we know from Part ii a) that the 
asymptotic variance of the means of the iP  is zero. Since the asymptotic mean of the means is p, 
we have that for any 0   there must exist a sub-subsequence, also with positive density (in 
fact, the same positive density as the subsequence), such that the means of all iP  in the sub-
91 
subsequence lie in  (   ,   )p p   . Without loss of generality, assume p < 0.5. Choose   such 
that (  )H p   is within / 5   of ( )p . This is possible because the entropy H  is a continuous 
function. Take iX  to be in the sub-subsequence. But then by Lemma 6, the entropy for iY  is at 
least / 4  greater than ( )H p . This means its entropy must be greater than that of any point mass 
in (   ,  )p p   . But since the mean of iY  is in the interval (   ,  )p p   , this leads to a 
contradiction, because of the earlier result about the maximum entropy iP  with a given mean 
being a point mass.  
Assume ii) is false. Then there is a subsequence of positive density such that the 
asymptotic mean entropy is greater than ( )H p . But then this subsequence must contain a sub-
subsequence of positive density such that the means of the iP  in this subsequence are bounded 
away from p . This would lead to a contradiction. This proves Lemma 7.  
We now see that if the original assumption is true, there is a subsequence of the trial that 
has positive density, and with mean asymptotic entropy bounded away from and above by the 
entropy of the optimal entropy design. Thus, if the trial is to achieve the maximal asymptotic 
mean entropy, there must be another subsequence of positive density with asymptotic mean 
entropy greater than ( )H p . However, if this is true, this other subsequence must contain a sub-
subsequence with means of the iP  in this sub-subsequence are bounded away from p. However, 
this would lead to a contradiction QED  
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 Now we prove the other direction of the Optimal Entropy Theorem. Assume the two conditions 
hold. Then for all ε, δ > 0 there exists N  such that for any n N  the area of the iP  in 
( , )      is greater than 1   . This is due to Chebyshev’s inequality. Then it follows that  
 [ ( )] (1  )min ( ), ( ) ,iE H P H H         
because ()H  is concave.  Also, for 1/ 2,    
 [ ( ( ))] max ( ), ( )E H P n H H      , 
for ε sufficiently small. Thus as ε, δ → 0, 
or as ,  [ ( )]  ( )iN E H P H    if ρ≠1/2. If ρ = 1/2 then this still holds because 
(1  )min( ( ), ( )) [ ( )] (1/ 2).iH H E H P H        
Thus, the maximum asymptotic mean entropy is achieved for any such design. QED 
 
Proof of Theorem 2, Part i). 
Break { }
kn
P  into two subsequences, one where ( )
k jn
E P     and one where ( ) .
kn
E P      
At least one of these subsequences must be infinite. WLOG assume it is { }
k jn
P , the first 
subsequence. Then for each 
k jn
P , the density of 
k jn
P   must gave positive probability on the 
interval [ / 2,1 ]  , since if it did not, ( ) / 2
k jn
E P      , a contradiction. Moreover, this 
positive probability is bounded from below for all k jn  by a quantity satisfying: 
1
(1 ) (1 )( )
2
b bp p      , therefore 
1
1 1 2 0
12 2
1
2
b b b bp p p p

  
 
      
 
. 
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Let P
nk j
S
F  be the cdf of  ( )
k j
nn P   . Then 
1
1 ( )
2
P
nk j
bS
F n p   for any n. 
Since 
1
2
n   is unbounded, it becomes impossible 
nk j
PS for to have a 
2(0, )N  attractor 
distribution, which is a contradiction.  
Thus, we see that ( ) 0nE P    and therefore ( )nE P  , which satisfies the first condition of 
the Optimal Entropy Theorem.  
Lemma 8: lim ( ) 0n nVar P   
Proof of Lemma 8. 
( ) ( )n nVar P Var P    and nP   has support only in [ ,1 ]   . We proceed by contradiction. 
Suppose that ( )nVar P  does not approach zero. The ( ) nVar P  does not approach zero, so there 
must be some 0   and infinite subsequence 
kn
P  such that ( )
kn
Var P     for any kn . 
By Lemma 8 there exists m such that 
1
| [ ] |<
4k
nE P   . Then for each knP   the 
density of 
kn
P must have positive probability in the set  
 
3 3
,1   ,
4 4
\          
 
. 
Thus must always have positive probability on  
3
4
x n , which is unbounded.  Thus 
P
nS  cannot approach 
2(0, )N  in distribution, which is a contradiction.  
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Since both conditions of the Optimal Entropy Theorem are satisfied, 
P
nS  mush have asymptotic 
optimal entropy. The proof for 
Q
nS  is the same.  
 
Proof of Theorem 2, Part ii). 
Let the sequence of random variables nR   be defined as: 
( )n nR Q

 

   . 
Then we see that: 
2( ) ( ) (0, )n n
D
n R n Q N

  

    . 
Let ( ),  ( ) and ( )P Q Rn n n n n nS n P S n Q S n R        . 
Clearly the sequence of random variables   1 1 2 2 3 3, , , , , ,... 
P R P R P R
kB S S S S S S converges in 
distribution to 
2(0, )N  . By the Skorohod Representation Theorem, we know that there is a 
sequence  kT  such that: 
i) Each random variable Tk has the same distribution as each Bk 
ii) 2~ (0, )k
P
T X N   
Now note that as k   
2 1 2 2 1 2( ) ( ) (1) (1) (1)
R P
k k k k k kS S T T T X T X op op op            
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because 
k
P
T X . Here y=op(x) if y/x approaches 0 in probability. Thus 
(1) ( ) ( ) (1)
1
                           ( )
1
                           ( ).
R P
k k n n
n n
n n
S S op n R n P op
R P op
n
R P op
n
 
 
      
    
  
 
Lemma 9: If we have: 
i) { },{ } n nA B are sequences of random variables with support on [0,1] 
ii) ( )n n nA B op    
iii) n  is a random variable such that and 0n n
    is a constant 
iv) ,n nA B are bounded away from zero in probability 
Then ( ) ( ) ( )n n nH A H B op   , where () H means entropy. 
Proof of Lemma 9. 
First, we establish that: (| |) | | ( ) ( ) |H x y H x H y   . If x,y >1/2 or x,y <1/2, then this statement 
follows from the concavity of H(). Now assume otherwise. Without loss of generality let x < y. If 
y – x < 1/2 then the statement again follows from the concavity of H(). If y – x   1/2 then y – x is 
closer to 1/2 than either y or x, so the desired result follows. By the Continuous Mapping 
Theorem, H(op(1)) = op(1). By the power series for H(), ( ) (log( ))nn op op n
   . Thus 
(| |) (log( ) / )n nH A B op n n
  . Because ,n nA B   are bounded away from zero in probability, 
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 ( ) ( ) / ( )n n n nH A H B H A B   is (1/ log( ))op n  due to the value of the derivative of the entropy 
function. Thus ( ) ( ) (1/ )n nH A H B op n
  . This is the definition of ( ) ( ) ( ) n n nH A H B op    
 
Let 1/ 2   . It then follows from Lemma 9 that ( ) ( ) (1/ )n nH R H P op n  . 
Now we proceed in a manner similar to the proof of the Optimal Entropy Theorem. 
 
 
0
0
( ) (1 )
        [( ) ] [( (1 ) ) ]
!
                     [ ( ) ((1 ) ) ]
! !
!
                     ( ) (1 ) [ ]
! !
                     
n n n
k k
n n
k
i k i
n
i
k
i k i i k i
n
i
R Q Q
E R E Q
k
E Q
i k i
k
E Q
i k i
  
  
  
 

 
 

 
 

 


 

      
  
 

 




 0
!
( ) (1 ) [ ] [ ],
! !
k
i k i i k i
n n
i
k
E Q E Q
i k i
 
 
 




 
by Jensen’s inequality since [ ] 0nE Q    
 0
!
                                         ( ) (1 ) [ ] .
! !
k
i k i k
n
i
k
E Q
i k i
 
 


 

  
Since , 
i k i
n nQ Q

 have positive covariance, is equal to [ ]
k
nE Q . 
We know from power series that: 
2 3 4
(1 )log(1- ) ( ) ...
2 2 3 3 4
n n n
n n n
Q Q Q
Q Q Q     
 
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And similarly for nR .Thus since [ ] [ ] n nE Q E R and [ ] [ ]
k k
n nE Q E R : 
2 2
[(1 )log(1 )] [(1 )log(1 )] [( )] [( )]
2 2
1
                                                                         = ( ( ) ( )),
2
n n
n n n n n n
n n
Q R
E Q Q E R R E Q E R
Var Q Var R
        

 
hence [ ( )] [ ( )] ( ( ) ( )),n n n nE H Q E H R Var Q Var R   by the symmetry argument used in the proof 
of the Optimal Entropy Theorem. 
Because of the moment condition in the statement of the theorem, we know that the 
random variables converge to 2 2 and   respectively. Thus there exists Nm  such that 
2 2
2 2
( ) ( )  for any  
2
( ) ( )  for any  .
2
Q R
j j
j j
Var S Var S j m
Var Q Var R j m
n
 
 

  

   
 
Hence for any b > m, 
2 2
1 1 1
1
[ ( )] [ ( )] ( ) .
2
q q q
n n
n m n m n m
E H Q E H R
n
 
     

     
As 
1
1
  
q
n m
q
n 
  diverges, so we have for any q c N   
2 2
1 1 1
2 2
1 1 1 1
1
[ ( )] [ ( )] ( )
2
1 1
[ ( )] [ ( )] [ ( )] ( ) .
2
q q q
n n
n n n
q q q q
n n
n n n n
E H Q E H R
n
E H Q E H P E op
n n
 
 
  
   

 

  
  
   
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nP  and nR each only have support on [0,1]. So the 
1
( )op
n
 random variable only has support on 
[-1,2]. Now we have the following lemma: 
 
Lemma 10: Let ω be a sequence of random variables with support on [-1,2] such that 
1
( )op
n
  . Then the sequence of random variables [ ]E   is also 
1
( )op
n
 . 
Proof of Lemma 10. 
For any ,  1 and  such that for any ,b N n b       
| |
(1)  Pr < >1
1/
n
n

 
 
 
 
, therefore (1 ) 2  
1/
nE
n

  
 
   
 
 because  and 2  are the most 
extreme values. Hence  
1 3
| [ ] | [((1 ) 2 )] max( , ).nE
n n
          
Also *
3
| [ ] | max ( , )nE
n
   , where max( , ) inf(max( , ))     over all ,  where (1) holds. 
As n  
*max ( , ) 0    so,  
                                                         
[ ]
3max( , ) 0
1/
nE
n

   . 
So 
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[ ] 1
0,   is ( )
1/
n
P
E
op
n n

  
Returning to the previous sum we have for any :q c N   
2 2
1 1 1 1
1 1
[ ( )] [ ( )] [ ( )] ( ) ,
2
q q q q
n n
n n n n
E H Q E H P E op
n n
 
   

       
which becomes after Lemma 10: 
2 2
1 1 1 1
1 1
[ ( )] [ ( )] ( ) ( )
2
q q q q
n n
n n n n
E H Q E H P op
n n
 
   

      . 
Where 
1
( )op
n
 denotes a point mass 
1
( )op
n
 random variable.                      
Then there exists g N such that for any ,n g  
                                                                     
1
( )
1
1 2
op
n
n
 . 
Thus for N, d d g  : 
2 2
1 1 1
1 1 1
( ) ( )
2 2
d d d
n g n g n g
op
n n n
 
     

     . 
Since 
2 2
1 1
1 1
( ) ( )
2
g g
n n
op
n n
 
 

   is finite, let it equal the constant cF . Then 
2 2 2 2
1 1 1 1 1
1 1 1 1 1
( ) ( ) ( ) ( )
2 2 2
d d d d d
c c
n n n g n g n g
op op F F
n n n n n
   
       
 
           . 
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Then   
2 2 2 2
1 1 1 1 1
1 1 1 1 1
( ) ( ) . 
2 2 2
d d d d d
c c
n n n g n g n g
op op F F
n n n n n
   
       
 
            
As d increases, this final sum eventually becomes negative, since diverges. It stays negative. 
Thus for all d greater than some 1d   we have:   
                                     
1 1
[ ( )] [ ( )] ,
d d
n n n
n n
E H Q E H P 
 
    
where 0n  . Hence 
1 1
1 1
[ ( )] [ ( )]
d d
n n
n n
E H Q E H P
d d 
  . Which means the entropy of patients in 
the first trial permanently exceeds that of the second. QED  
